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Abstract
Modelling human immune response dynamics to Mycobacterium
Tuberculosis infection
Department of Mathematical Sciences,
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc. (Mathematics)
December 2017
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB) still poses a great chal-
lenge to the well-being of the population, particularly in Sub-Saharan Africa. The ability
to trigger strong mounted cellular response within the host environment is daunting.
The host cell depends on the robust adaptive cellular immunity to battle MTB infection.
Of these, localizing TB bacteria by the development and the sustainability of a strong
T helper type 0 cells (Th0) response is key to thwart MTB dissemination. The factors
fuelling TB pathogenesis include, Human Immunodeficiency Virus (HIV) and TB co-
pandemic, the growing burden of Multidrug-resistant TB (MDR-TB) and Extensive drug
resistant TB (XDR-TB), and incompetency of host cell to kill MTB. The survived MTB
load can trigger Latent TB infection (LTBI). In addition, the largely unknown biology
of the host-MTB interaction, is yet to be elucidated. In this study, we develop a math-
ematical model capturing and addressing key dynamics of the adaptive host immune
response to MTB infection. Of these, we consider the interplay of MTB with three dis-
tinct subsets of key immune cells and cell signalling molecules, namely; macrophages,
T cells and cytokines. Furthermore, we explore the mechanisms of phagocytosis, T cells
priming with delay, macrophage activation leading to lysis of infected cells. To estimate
unknown parameters in the model, we perform curve fitting to experimental data of an
infected mice using non-linear least square and Bayesian-based Markov Chain Monte
ii
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Carlo methods. We use the reproductive number R0, to address factors altering the sta-
bility of the system. This study provides insight on how the immune system can be
amplified to clear the survived intracellular MTB.
Keywords: Tuberculosis, granuloma, immune system, macrophages, cytokines, T cells,
Mycobacterium tuberculosis.
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Tuberkulose (TB), wat veroorsaak word deur Mycobacterium tuberculosis (MTB), bied
steeds ’n groot uitdaging tot die welvaart van die bevolking, spesifiek in Sub-Sahara
Afrika. Die vermoë om ’n sterk gemonteerde sellulêre reaksie in die gasheeromgewing
te wek is ontmoedigend. Die gasheersel is afhanklik van die robuuste aanpasbare sel-
lulêre immuniteit om MTB infeksie teen te veg. Van hierdie, is die lokalisering van TB
bakterië deur die ontwikkeling en volhoubaarheid van sterk T helper tipe 0 selle (Th0)
reaksie die sleutel om MTB verspreiding te stuit. Die faktore wat TB patogene aanhelp
sluit in ’n Menslike Immuniteitsgebreksvirus (MIV) en TB mede-pandemie, die groei-
ende las van multidwelmbestande TB (MDR-TB) en uitgebreide dwelmbestande TB
(XDR-TB), en die onvermoë van die gasheersel om MTB dood te maak. Die oorlewende
MTB lading kan lei tot ’n latente TB infeksie (LTBI). Daarbenewens moet die grootliks
onbekende biologie van die gasheer-MTB interaksie nog toegelig word. In hierdie stu-
die ontwikkel ons ’n wiskundige model wat die sleuteldinamika van die aanpasbare
gasheerimmuunreaksie tot MTB infeskie opvang en aanspreek. Uit hierdie beskou ons
die interspel van MTB met drie verskillende deelversamelings van sleutel immuunselle
en selseiningsmolekules, naamlik: makrofage, T selle en sitokiene. Verder verken ons
die meganismes van fagositose, T-sel primering met vertraging, makrofage aktivering
wat lei tot lise in besmette selle. Om onbekende parameters in die model te benader,
iv
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pas ons ’n kurwepassing toe op eksperimentele data van besmette muise en gebruik
nie-lineêre kleinste kwadrate en Bayesies-gebaseerde Markov-ketting Monte Carlo me-
todes, onderskeidelik. Ons gebruik die voortplantingsgetal R0 om die faktore wat die
stabiliteit van die stelsel verander, aan te spreek. Hierdie studie gee insig oor hoe die
immuunstelsel versterk kan word om die oorblywende intrasellulêre MTB te verwyder.
Sleutelwoorde: Tuberkulose, granuloom, immuunstelsel, makrofage, sitokiene, T selle,
Mycobacterium tuberculosis.
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Chapter 1
Introduction
1.1 History of Tuberculosis (TB)
The primary evidence of Mycobacterium (M.) tuberculosis (MTB) in both human and
animal was spinal Tuberculosis, was attributed to spine bones with holes observed in
8000 BC [1]. In those days, the origin and morphology of Tuberculosis (TB) were still
to be elucidated. Richard Morton (1637-1698) and others disputed inheritance as the
transmission mode of TB. Without biological evidence they strongly argued TB had
three phases namely; early TB infection, reactivated TB and active TB and, could be
contracted by exposure with the infected individuals [2]. The cause of the disease was
undiscovered until Benjamin Marten (1704-1722) postulated that infection was caused
by a living creature calledbacteria [1]. It was Robert Koch (1843-1910) who successfully
extracted the tubercle bacilli and demonstrated that TB is characterised by two stages,
primary and secondary disease, respectively [2]. To date, we still rely on Phillip Klenche
(1813-1881) hypothesis of possibility that as few as 10% of infected individuals fail to
stop the dissemination of the TB bacteria, leading to active TB [3].
In 1865, Jean Antoine Villemen demonstrated that Tuberculosis (TB) is an infectious
(transmissible) disease [1]. However, the mechanism in which the discovered tuber-
cle bacilli invade the immune system was still unknown. Of these, a committed ger-
man physicist and scientist, Robert Koch (1843-1910) was the first to successfully dis-
cover that TB is caused by MTB [2, 3]. This discovery brought to light the morphology
of the tubercle agent, in both animals and humans [4]. Although the phenotype and
pathogenesis of MTB were still unknown. Several authors approximated that MTB orig-
inated 15000-20000 years ago [38]. However, in-depth research on MTB strains from
1
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East African led to strong evidence that TB bacteria is 2-3 million years old [38]. This
evidence supports the concept of a ancestral strain, that it is the original agent of the
modern pulmonary Tuberculosis, which contradicts the hypothetical claim that MTB
species matured from M. bovis, M. microti, M. canettii and M. africanum [1, 2, 38], respec-
tively. In addition, it was strongly believed MTB genus evolved from M. bovis by human
consumption of unpasteurized milk [1], supporting the transmission mode from cattle
to human [1, 3]. The knowledge of TB was evolving with years due to its devastating im-
pact in public health. The first animal experiments and animal models were performed
and analysed on rabbits and guinea pigs [39]. Although the models significantly paved
ways for new developments, they were limited by the availability of data.
1.2 Epidemiology and drug tolerance of Mycobacterium
Tuberculosis
After the discovery of the tubercle bacilli, the first peak of TB cases were observed in the
Europe, during the 19th century [47]. However, the number of TB cases and mortality
declined in the 20th century as a result of awareness due to the immense TB deaths. This
improved public health intervention methods and the availability of TB front-line drugs
composed of isoniazid, rifampin, pyrazinamide and ethambutol [90], significantly con-
tributed to the decline of TB prevalence [38, 47]. Despite the challenge of drug-resistance
TB, the current TB burden in Africa, is an existing evidence that TB is fuelled by socio-
economic status and poverty [1, 41].
TB symptoms include coughing of blood, rapid weight-loss, chest pains and lack of ap-
petite [30] and this is also the case for latent TB infection (LTBI), which is asymptotic with
10% chance of reactivating [40]. An insight of MTB anatomy and phenotype led to de-
velopment of diagnostic tools. To date, skin test, sputum test, Interferon gamma release
assays (IGRAs) and other test assays, are used to detect TB [31]. However, the accuracy
and time efficacy of the diagnostic tools is a shortfall [31]. We still lack rational and
sensitive diagnostic tools that can quickly and efficiently detect TB [5], and also LTBI.
The sputum test can cause false positives, i.e., failing to detect MTB load inside a spu-
tum [31]. In vivo, this leads to untracked TB growth, and causing infected individuals to
be highly infectious [43]. However, with the new advanced technologies, several diag-
nostic tools are still on the clinical trials [45]. Of these, some diagnostic tools are limited
to the nature of TB. For instance, the Nucleic acid amplification tests (NATs) are limited
to only detection of pulmonary Tuberculosis (PTB). In fact, it can be used to confirm the
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results from sputum tests [45]. The new Line-probe assays is well-developed to extract
co-ordinates, that are used to detect phenotypes of MTB that are able to trigger drug
tolerant MTB [4, 33, 45]. However, these tools are only available in developed countries
such as United States of America (USA), Germany and Belgium [45]. The availability
of these advanced TB assays in developing countries where TB remains widespread is a
necessity.
It took about 13 years (1908-1921) for the discovery [1] by french scientists Albert Cal-
mette and Camille Guerin, the currently used TB vaccine, Bacillus Calmette Guerin
(BCG) [1]. Despite the availability of this vaccine, the effectiveness and efficacy of
the vaccine remain debatable. TB persistence in terms of prevalence and incidence is
of great public health concern. Currently, factors fuelling epidemic burden, includes
socio-economic, poverty, heterogeneity within individuals [4] and TB treatment time
constraint [5].
There is a growing challenge of drug-tolerance, particularly extensively drug resistant
TB (XDR-TB) [30], arising when resistant to second line drugs occur on top of multi
drug resistant TB (MDR-TB) [32]. The phenotype of the MTB is a key factor in deter-
mining the immune tolerance and dissemination of the bacteria. The observation from
real time tracking in both human and animal models revealed interesting characteristics
of tuberculous bacilli. Its ability to switch avirulent phenotype, pose a challenge in the
drug development [5]. Recent laboratory observations by John Szumowski and others
showed that non-replicating MTB can cause drug tolerance [23]. Of these, intracellular
MTB within macrophages turn-on efflux pumps, the proteins inducing MTB drug toler-
ance [23]. The virulent MTB strain such as H37Rv have been shown to knock down the
immune system faster [29, 33, 39]. This is validated by laboratory observations using
animal models [39].
Africa has the highest global burdened of Human Immunodeficiency Virus (HIV) and
TB co-infection of about 28% as reported by the World Health Organisation (WHO) in
2014 [40]. TB persistence is intensively fuelled by drug resistance and co-infection (HIV
and TB) with an excessive 50 % risk of TB recrudescence [40, 43, 44]. In South Africa
(SA), despite the wide availability of TB front-line drugs, SA is still highly burdened
with a growing challenge of drug tolerance TB [40]. The WHO has made significant
contribution in the control of TB, highlighting key future research areas to be resumed.
However, multi-drug resistant TB makes this pathogen the most lethal bacteria than it
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was in the pre-antibiotic era [37]. It is clear that mutant TB has evolved strategies to
survive intra-cellular anti-microbial attacks by the host cell. Understanding the biology
of the MTB infection can be a steppingstone in restricting the pathogenesis of the MTB.
1.3 Immunology of Tuberculosis (TB)
TB is an aerosol infection on several parts of the organs, its ideal site is mainly lung
tissues, resulting in pulmonary TB [5]. It is still unclear whether the lung is a pleasant
habitat for MTB. The rationale is likely to be its ability to manipulate host system and
survive in the lymph tissues [15]. Of these, the transmission dynamics are unique, com-
pared to other leading infectious diseases. As few as 1-5 bacteria from a single droplet is
sufficient to cause an infection [6]. This is specific to MTB since most infectious diseases
require more than 1000 bacteria [6], or even more to initiate infection. Studies in rabbits
which provided insights associated with the transmission dynamics of MTB, showed
that fewer MTB load led to infection [24]. This mechanism supports the notion that tu-
berculous bacteria are unable to regulate the immune system [37], whereas most of the
MTB will trigger the immune response which can effectively contain the MTB infection
at the innate immunity [34, 36].
MTB infection requires a robust acquired cellular response. Although molecular and tis-
sue scales are also important in controlling MTB infection. The cellular response to MTB
infection have been shown to be the determinant in the disease outcome. Interestingly,
the immune system can halt the activeness and dissemination of MTB. However, clear-
ing MTB antigens is laborious due to the ability of the MTB to switch from replicative
(growth) to non-replicative (dormancy) states [91]. The way in which the acquired re-
sponse is expressed when primed by immune cells is critical for an competent immune
system.
The regulation of both the innate and adaptive immunity remain controversial. There
is a critical relation between the two immune responses, that still needs to be clearly
described. During the early stages of MTB infection, macrophages receive signals from
dendritic cells to locate and engulf the bacteria [37] to perform phagocytes [69]. How-
ever, the pathogen is able to evade this process [65]. In a study conducted in 2001 [65],
it was observed that during the innate immunity, the hydrogen peroxide (oxidizer)
is used by murine macrophages as a weapon to annihilate mycobacterial activities.
Specifically, to facilitate the process of ingesting and killing the MTB [65]. Furthermore,
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intracellular MTB within macrophages deplete nitric oxide and nitrogen, secreted by
Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α) [23, 65], respec-
tively. A study in murine models showed that during phagolysosome fusion, MTB se-
crete ammonia, sulfatides and related glycolipids to survive under harmful acidic condi-
tions, with potential of hydrogen (PH) value of approximately 5.0 [65]. In addition, the
lack of lysosome synthesis possibly due to microbial ammonia was observed in mice
macrophages afflicted by TB bacilli [65]. However, this phenomenon was not seen in
mice macrophages that are not infected with TB [65].
The switching from innate to adaptive immunity is a resulting failure of non-specific
(innate) immunity which may be caused by the phagocytosis collapse [15, 49, 65]. The
adaptive immunity is a network containing cells, molecules, cytokines and chemokines.
Of these, the activation, priming and functioning of the immune system are induced by
the phenotype and perturbations of the MTB [26, 61]. The keystones of the adaptive im-
munity are primarily T-lymphocytes, particularly CD4+ T cells. Although, in the past,
T-lymphocytes were not recognized as key mediators in TB control [36]. Recent studies
have shown that lymphocytes are crucial in controlling TB and other leading communi-
cable and non-communicable diseases such as, HIV and Cancer [36].
The organization of cells at the site of MTB infection, to restrict and contain the bacteria
from replicating is formed, called granuloma [15, 19, 20, 22]. The granuloma is com-
prised of macrophages, class 1 and 2 major histocompatibility complex (MHC) mediated
T cells, antibody cells (B cells) and other immune cells [19, 65]. The potency of the adap-
tive immunity lies on the receptors from cells of the innate immunity. However, the key
mode of protective immunity used to confer successfully cell immunity to contain MTB
is mainly the granuloma [49]. The granuloma is facilitated by strong response of class 2
MHC CD4+ T cells and CD8+ restricted by MHC class 1 molecules [10, 25, 50]. However,
there is little experimental data to verify the protective effects of CD8+, which includes
production of IFN-γ and lysis of infected macrophages were redundant [25, 62, 65]. This
suggest that CD4+ T cells are the long serving soldiers of the immunity against TB [65].
Indeed, HIV infection in human greatly depletes the CD4+ T cells and this has been
shown to exacerbate the chances of TB infection or reactivation [30, 65]. The dynamics
of MTB at different stages are yet to be understood [65].
The potency of TNF-α in facilitating the stability and maintenance of the granuloma
is well described by several study groups. At the granuloma stage, TNF-α controls
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the movement and activities of chemokines and related receptors [23, 65]. This con-
trol by TNF-α ensures that effector cells and other cells are recruited to the granuloma
site [44, 58, 65]. Interestingly, TNF-α down-regulates the receptor CCR5 involved in
recruiting immature macrophages (monocytes) [58, 65]. This suggest that TNF-α is in-
volved in the differentiation of monocytes to rested macrophages [58]. This might be
one of the mechanism of stabilizing the granuloma, by ensuring the ideal density of
rested macrophages are recruited to the granuloma.
It has been shown that MTB is able to inhibit the expression of MHC class 2 molecules
by infected macrophages [49, 65]. This results in a delayed T cell priming and prolonged
T cell response [65]. In fact, observations from human studies evince that MTB blocks
T helper type 1 (Th1) cells [67]. Nonetheless, the ability of the pathogen to promote T
helper type 2 (Th2) cells response does not implicate MTB persistence [65]. This obser-
vation is yet to be elucidated by considering the in host TB granuloma dynamics [65]. In
addition, investigating the relation of Th1 and Th2 response can reveal potent dynamics
of TB granuloma.
The Th2 type cytokine IL-10, is considered the MTB beneficiary cytokine [76]. Its ability
to deactivate cells and inhibit several activities describe the default anti-inflammatory
immune response [58, 76]. However, the ability of MTB to mediate IL-10 activities re-
mains a hurdle. The pathogen has been observed to use IL-10 as a tool for stimulating T
cells differentiation (Th0 to Th2) [50, 51]. The role of IL-10 in promoting IL-4 is still to be
elucidated. In most human MTB infection, the IL-4 is not highly expressed and its key
anti-inflammatory role remain controversial. The ability of the pathogen to mutate and
become drug tolerant are all challenges to the immune system.
Both avirulent and virulent TB strains exhibit different modulating strategies, and in-
duce different immune response mechanisms [36]. Lalita and colleagues observed that
MTB pathogen use the granuloma as a survival tool, it employ the ESX-1 secretion sys-
tem to recruit rested macrophages through manipulating host Matrix metallopeptidase
9 (MMP-9) secretion system [37]. This suffice to deduce MTB benefits more from the
granuloma. Understanding of the host-pathogen environment is crucial to identify fac-
tors that make MTB conquers the host response, and also identify elements within the
immune system which can be targeted and amplified by the vaccine.
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1.4 Problem statement
Tuberculosis remain one of the epicentre of public health, globally. Deaths due to TB
were estimated to be 1.7 million annually in 2015 [71]. Approximating the number of TB
deaths in the presence of HIV infection, can provide daunting insight of the expected
number of TB deaths. In addition, the low risk of 5 - 10% is misleading [30, 38, 40],
when considering the challenge of 15% TB adults risk and the stumbling block of XDR-
TB. This XDR-TB alleviate the ability of the host to significantly prevent TB persistence.
The TB granuloma is a structure used by the immune system to combat and prevent TB
bacteria from spreading [71]. The emerging evidence suggests the granuloma benefits
both the host cell and pathogen [28]. Triggering of this balance possibly due to aging or
depletion of key cells, such as TNF-α, can result in reactivation of TB [75]. Additionally,
the stimulation of bacterial protein, resuscitation promoting factor (Rpf ), prompt TB re-
activation [78].
MTB pathogenesis is aggravated by the largely unknown host-pathogen dynamics. We
are faced with a challenge of both human and pathogen evolving, leading to complex-
ity in screening host-pathogen interactions [59, 65, 77]. In addition, the biology of the
granuloma from literature ignores different mechanisms used by MTB to circumvent
strong cellular response [69]. The study of host-MTB interaction is given little attention,
when considering the research on the immunology of TB. In fact, the dynamics of cel-
lular response to MTB infection at the granuloma stage are not completely understood.
In addition, most models were aimed at elucidating dynamics of infectious diseases at
a population scale, see for instance [75]. As such, there are little efforts and very few
mathematical approaches to understand the cellular dynamics of active TB and LTBI,
respectively. Understanding host cell-MTB interaction can sharpen our insight into dif-
ferent stages of TB, and provide basis for drug and vaccine development that will yield
long lasting immunity [75, 77].
In this study, we mathematically analyse and describe potent MTB infection dynam-
ics at a cellular scale. In addition, we describe the interplay of both pro-inflammatory
and anti-inflammatory cells and predict candidate immune cell biomarkers for potential
protective immunity and vaccine development.
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1.5 Motivation
Tuberculosis bacilli has proven to be the smartest bacteria in the history of infectious
diseases, with its mechanisms to evade a strongly mounted immune system [36, 43].
The latter survived tuberculous bacilli leads to LTBI [44], with 90% chance of non-
reactivation of TB. The remaining 10% re-activates. Moreover, TB cases are fuelled by an
emerging challenge of drug tolerance and undiagnosed TB positive (TB+) patients [40],
toughening the advancement of TB control. In 2000, World Health Organization (WHO)
aimed at reaching 70% of TB case detection rates and 85% treated rates of pulmonary
TB [40]. This highlights of unachieved targets set by WHO is disturbing. In 2015, glob-
ally, the estimated prevalence of TB was 42% and decline of 1.5% annual average inci-
dence was reported in 2015 [40]. Since only 63% of 9.6 million people estimated to be
TB+ were detected and tested [40]. The latter undiagnosed (37%) likely contribute to
new infections that accelerate rising of TB [36, 40]. Of these, in 2014, deaths due to TB
were reported to be approximately 16% ( 11% HIV− and 6% HIV+) [40].
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Table 1.1 shows the models aimed at understanding cellular dynamics of MTB infec-
tion. The studies on host-MTB are limited due to the complexity, unavailability of data
and inaccessibility of lung biopsy samples [46]. Furthermore, very few MTB proteomes
have been extensively studied. Nonetheless, protein database sites such as STRING
and mint, which can be accessed on http://string-db.org/ and http://mint.bio.
uniroma2.it/, respectively, can be a useful tool to explore other sets of MTB protein-
protein functional interactions. Additionally, animal models, in particular, widely stud-
ied mouse and zebra-fish models, provide essential tools that can be integrated with hu-
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man models, to amplify cells facilitating cellular response to MTB infection. Although
both humans and animals have different cellular structure, integrating animal models
to human models in understanding diseases, has been a growing success. The animal
granuloma in vivo models are assumed to closely resemble human TB dynamics [46],
since both animals and humans share some biological features and functioning. In ad-
dition, it has been shown that low and high TNF-α concentrations in mice is associated
with TB progression [44, 46]. This mechanism was also observed in TB patients at Chris
Hani Baragwanath hospital [87]. Patients with active TB had low and elevated TNF-α
concentrations, respectively. We need to study and understand the host-pathogen inter-
action, to model how the MTB circumvent the robust host defence.
1.6 Objectives of the project
In this project,
(I) We model the host immune response dynamics to the reactivation of the MTB in-
fection using differential equations to elucidate cellular response to MTB infection.
(II) We fit the model to the experimental data to estimate model parameters using
both, non-linear least square (NLS) and Bayesian-based Markov Chain Monte Carlo
(MCMC) methods, respectively.
(III) We investigate components of the immune system that promote MTB growth.
(IV) In addition, we explore and analyse factors destabilizing the functioning of host
cells.
(V) We address potent immune cells that can be amplified for therapeutic design.
1.7 Project outline
In the previous chapter 1, we state the background of TB and addressed the epidemiol-
ogy and drug tolerance of MTB. In addition, in Chapter 2, we elucidate novel approaches
related to the immunology of TB and also, we review mathematical models related to
the cellular response of MTB infection. In chapter 3, we develop a mathematical scheme
to investigate the human immune response to MTB infection. In this Chapter 3, the
biology of each model equation is described. In Chapter 3, we perform mathematical
analysis, to inspect the stability of the model. In Chapter 4, we present the analysis and
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results of the model, this include model fit, estimated parameters, fitted plots, numerical
simulation and sensitivity analysis. In the last Chapter 5, we use obtained results to give
recommendations and conclude the project.
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Literature Review
The fight to control and eradicate TB prevalence and incidence remains a hopeless battle.
The recent statistics on TB attest to this, especially in Africa with an estimate of 31% TB
prevalence. Moreover, Southern Africa has the highest proportion of HIV+ individuals
of which , about 45% receive Isoniazid Preventive Therapy (IPT) as a preventive treat-
ment for LTBI [40, 42]. Additionally, approximately 74% of HIV-TB co-infection cases
occurs in Africa [42]. It is necessary to investigate the relationship between these two
lethal infections that manifest and kill its host quickly. To achieve the goal of combat-
ing TB and finding biomarkers of TB that can be used for designing effective diagnostic
tools and development of rational human TB immuno therapy, there is a need to eluci-
date and understand the interaction between humans and MTB. It is therefore important
to study and acquire extensive knowledge on the functioning of the immune system at
different scales.
The immune system is a well-built stable network of cells, including Bone-marrow cells
(B cells), T lymphocytes cells (T cells), defense cells (macrophages), dendritic cells also
known as agent presenting cells (APC), and others [35, 47]. The main role of the immune
system is to fight against unrecognised foreign invaders, such as germs, viruses and
other pathogens [35]. The macrophages are the first to encounter the foreign pathogens,
priming and stimulating other cells to perform activities that will facilitate in clearing
out invaders in the system [35, 37, 46]. The default mechanism of "how the immune
system works" is relatively uncomplicated. However, the immune response and reg-
ulation is specific to a disease [35], which harden our ability to better understand the
immune response to an infection. This is exacerbated by the complexity of phenotype of
bacteria or viruses. Of these, MTB has shown to be a lethal bacterium, with 498 known
12
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strains [48]. These MTB virulent and avirulent strains are able to thwart the process of
phagosome, thus overcoming the host defense mechanism. The cell-mediated response
to MTB is a keystone component of the immune system in response to MTB. The T cells
are synthesized by APC or infected alveolar macrophages for differentiation, prolifera-
tion and release pro-inflammatory and anti-inflammatory cytokines [47]. To explore and
comprehend literature on cell mediated response to MTB, we only examine the role and
activities of cells involved in anti-MTB defense response.
2.1 T cells
The life process of T cells begin with thymus maturing to precursor T cells [60, 61].
Thereafter, both naive CD4+ and CD8+ circulate in the lymph gland to locate anti-
gens [61]. In addition, the effector and memory T cells mature from the naive T cells,
after receiving stimuli signals from distinct cells [61, 62].
CD4+ T cells are very potent in controlling chronic infections, in both humans and an-
imals [49]. Most of the T cells at the site of infection are the branch of CD4+ T cells,
called CD69+(∼ 50%) [65]. Alternatively, we have diverse population of T cells, CD4+,
which is comprised of T helper cells (i.e., Th0, Th1 and Th2) and Treg cells, CD8+ or Nat-
ural Killer Cells and γδ T cells, respectively. However, other subsets of T cells, except
CD4+, are redundant in protective immunity against life-threatening infections, such as
cancer, HIV and TB [63]. An observation from mouse models showed CD8+ is more
efficient than CD4+ in high bacterial load infection [49]. However, since TB is a result
of low-aerosol infection [64], the potency of CD8+ may be remarkable in high-aerosol
infections [49], indicating that CD4+ can be more effective against the MTB infection.
We review the potent and functions of CD4+ in the key role of immunity against MTB
infection. The majority of T cells response occurs at the adaptive immune system stage,
after the MTB antigen-presentation [50]. These T helper cells have time delay of approx-
imately 5 days before they can respond to signals for protection [36]. However, there are
other auto immune T cells migrating to the site of infection without binding to DC [50].
These T cells are flexible to organize for the battlefield (granuloma) of any infection. In-
deed, the deficiency of CD4+ in mice affected with TB led to prevailed and expansion of
MTB, merely due to unstable and not well-formed granuloma [49, 50].
The launching of the granuloma is classified into four aspects. initiation, accumulation,
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effector and resolution [36, 49, 50], respectively. The accumulation and effector stages
are critical for granuloma development [51]. In fact, CD4+ relocates and recruit stimulus
cells to the granuloma [51], during the accumulation stage. The dysfunctional of CD4+
T cells can be attributed to several virus or pathogen infections. For instance, novel ap-
proaches have demonstrated that HIV and TB co-infection depletes CD4+ T cells [50].
The deficiency of CD4+ contribute to unmaintained and unstructured granuloma, in-
creasing the risk of progressing to active TB.
There is very little research on how Naive T cells are induced and activated for protec-
tive immunity. Furthermore, the key mediator of Naive T cells activation are bacterial
spread or APC [36]. We can strongly hypothesize MTB exerts an inhibitory activity to
resist the function of the APC. This MTB likely switches phenotype to avirulent [26],
which may suppress the immune response. Unfortunately, the battle against this pre-
sumed puzzle requires data and extensive experiments on cells with the ability to recall
the MTB antigen, T memory cells [25, 50] and conventional T cells, which are able to
effectively differentiate into distinct effector cells. In fact, they are the prime targets for
cells to be amplified for remedy design.
The migration and movement of T cells require signals from chemokines and associated
receptors. For Th1 and Th2, chemokines CXCL and CCL facilitate signal pathways [49],
respectively. Intuitively, the impact of chemokines on granuloma function remain un-
clear. Recently, tumor necrosis factor-α (TNF-α) and C motif chemokine ligand 2 (CCL2)
have been shown to promote chemokine productivity [52]. In addition, it has been re-
vealed that CCL2 prematurely navigate macrophages to the infection site [43].
To date, we still lack human novel approaches that can efficiently address the immune
response dynamics after the MTB infection with low bacterial load. In addition, the se-
cretion of cytokines by T cells, during MTB infection is still not well understood. Of
these, human novel approaches aimed at understanding the roles of cytokines from the
MTB infection reactivation to the disease outcome with knowledge that T cells play a
fundamental role in TB immunity. The interdependence of macrophages, cytokines and
T cells are building blocks of the acquired immunity.
Herein below, we review and address literature on the potency of the cytokines, macrophages
and T cells during MTB infection. In particular, we inspect the role IFN-γ, necrosis
factor-α (TNF-α) and an array of interleukins; 2, 4, 10, and 12, respectively.
Stellenbosch University  https://scholar.sun.ac.za
15 2.2. Cytokines
2.2 Cytokines
The biological dynamics occurring in LTBI is unclear and not well understood. We are
yet to describe how different cytokines are triggered during different phases of MTB in-
fection. The cytokines regulate and facilitate the processes of most of the cells of the im-
mune system [65]. We review the collaboration of different protective roles of cytokines
during both active and dormant MTB. In addition, we include findings on screening
studies and experiments on both primate and non-primate models. We also review
cytokines dynamics during the MTB infection, precisely, T cells dependent cytokines.
Although, cellular response to MTB infection is comprised of different expressed cy-
tokines, its efficacy and involvement in the protective immunity are unique.
Different in vivo studies [29] on host-pathogen interaction have enlightened our knowl-
edge on cellular immunity against pathogenesis of TB. Recently, beads-based multiple
tool revealed IL-17 is associated with early protective immunity [12]. Despite this ob-
servation, individuals afflicted by TB still develop granulamous lesion [12, 47, 54]. The
validation of IL-17 potency is controversial, patients with active disease showed high
elevations of IL-17 [12, 54]. In addition, it is largely unclear what transpires in the early
stages of the infection.
The breakthrough of IFN-γ potency in MTB infection paved ways for advancement in
diagnosing TB. The IGRA use IFN-γ samples to detect MTB antigens, such as ESAT-
6 [15]. However, its limitation to detect and recognize other antigens of mutant MTB
is not heartening. The protective roles of IFN-γ during MTB infection include cell ac-
tivation and lysis of infected cells [55], respectively. In fact, it is the most expressed
inflammatory cell during both active and dormant stages of MTB [54]. Additionally,
observations on mice showed that IL-12 is key to control MTB infection. Indeed, the
cytokine proliferation induces IFN-γ for macrophage activation and apoptosis [51].
In most models, trial and error method is used to elect candidate cytokines involved
in termination of cells. Recently, the IL-2 has been shown to effectively mediate killing
of infected cells after the process of macrophage activation [12]. However, MTB block
phagocytosis or phagolysosome intra-cellularly by manipulating the function of IL-10.
Furthermore, at the granuloma stage, IL-2 recruit macrophage and T cells to the site of
infection [12].
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The fundamental role of TNF-α in sustaining the granuloma is well described and ex-
perimentally observed [54]. A study from a Chinese population observed that TNF-α
is a factor determinant of active tuberculosis outcome [66], supporting its role in the
granuloma maintenance. The ability of MTB to influence IL-4 response to halt TNF-α
pathways was noticed [54]. Nonetheless, it is not known which mechanism does MTB
employ to impede crucial protective operations by IL-4.
The interplay between IL-10 and MTB has been extensively analysed by several au-
thors [65, 76]. Murine models continue to be fundamental in understanding key roles
of IL-10, since human and murine share approximately 80% of IL-10 gene structure [55].
Furthermore, patients with lung TB secreted substantial amount of IL-10 and TGF-β [55],
and this was also observed in cancer patients [58]. In both cancer and TB, IL-10 and TGF-
β block T cells proliferation and deactivate macrophages [55].
The relevance of approaches demonstrating that IL-10 inhibition prevents disease sever-
ity is still to be clearly described. The in vivo mice model was used to examine the
efficacy of BCG vaccine and this efficacy was achieved after blockage of IL-10 [55]. In
addition, although different MTB strains manifest host immunity differently, IL-10 is a
prime target used by most extensively studied MTB strains [28]. Despite various harm-
ful activities of IL-10, there is no amplification of IL-10 from the current BCG vaccine.
2.3 Macrophages
Monocytes are released from the bone marrow to mature into alveolar macrophages [17].
In Greek language, "macro" symbolize larger and "phage" denote eater [57]. The appel-
lation suggests resident alveolar macrophages are the first defense cells to encounter
MTB [55], depending on the site of infection. Of these, macrophages are the best in-
ducer of effector cells and other T cells subsets [49, 50, 55].
The key determinant of intracellular MTB evasion lies in the continuous cross-talk be-
tween macrophages and other soldier cells [55]. Macrophages signalling with other cells
is Toll-like receptors 2 (TLR-2) dependent [15, 29, 55], and this signal pathway can be af-
fected by microbial activities [80]. The findings in [15], suggests the ESAT-6 protein
manipulates the host protein , β2 micro-globulin (β2M), in order to alter the operations
of MHC 1 class dependent antigen presentation and proliferation by macrophages via
IL-12 and phagocytosis [15]. In addition, β2M is crucial in the presentation of MHC 1
class associated viruses and bacteria [81].
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The capacity of the pathogen to delay immune system processes, negatively impact the
functioning of MHC 2 class molecules by macrophages [55], leading to untracked bacte-
rial growth intra-cellularly [15, 29]. The macrophages can be distinguished according to
their biological functions, such as polarization phenotypes [82, 83]. This involves rested
macrophages, infected macrophages and activated macrophages [8], respectively.
Rested macrophages await to engulf bacterial load without any protective operation [36]
and they have been shown to kill negligible MTB load. However, due to factors at-
tributed to MTB, they lack enough stimuli from pro-inflammatory cytokines, possibly
macrophage activator, IFN-γ. Moreover, strong evidence suggests rested macrophages
are the reservoir for MTB growth due to their lack of cytotoxicity [37, 59, 69, 72]. MTB
delays the process of macrophage activation by switching phenotype [47, 55].
The molecular dynamics of macrophages infected by MTB, remain our focal point in
terms of understanding and boosting cellular response to TB. Despite the well known
role of IFN-γ in macrophage activation, IFN-γ augment the MHC 2 class molecules lev-
els in macrophages [55]. In addition, TNF-α has recently been recognized to activate
macrophages within the granuloma [43, 44]. The various activities of IFN-γ and TNF-α
are the rational of assigning specific cells specialized roles to avert adverse effects. The
visual aid of this concept is the tissue damage caused by macrophages after killing cells.
This suggest every cell is uniquely robust for a particular immune function.
IFN-γ activated macrophages are well recognized by T cells. Of these, IL-12 allows
activated macrophages to signal for T cells differentiation [54, 55]. In contrast, MTB
adapts to harsh conditions within macrophages and block transformation of phago-
some to phagolysosomes [27, 29, 56]. This phenomenon benefits the pathogen to sur-
vive throughout host life time. Of these, other studies demonstrated the latter survived
MTB after bursting of activated macrophages switch phenotype to avirulent to escape
phagocytosis [29, 56, 86, 88].
IL-2 mediates killing of activated macrophages containing significant MTB load [15, 55].
The success of MTB lies in the survived MTB that is competent to reactivate the infec-
tion. The assumption of slim risk of MTBinfection may not be relevant considering the
array of emerging MTB strains.
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Furthermore, experiments from both human and non-human models have been exten-
sively reviewed with findings demonstrating MTB induces the matrix metallopeptidase
9 (MMP9) gene to recruit rested macrophages to the granuloma site [22]. In addition,
factors contributing to granuloma expansion are bursting of activated macrophages and
arrival of rested macrophages [21]
2.4 TB Granuloma models
The primary TB models were formulated in 1994 and 1996 [75, 79], respectively. This
models paved ways for investigating and understanding the biology of the host-MTB
interaction within the granuloma. In addition, utilizing human real time tracking de-
vices as a basis for elucidating the biology molecular structure of the granuloma can
enhance our knowledge of granuloma dynamics. Although most studies are limited to
unknown biology, which is exacerbated by the current poor diagnostic tools and the
complexity of the human genome [45, 54, 75]. Furthermore, advanced TB assays are ex-
pensive and not widely available to the poorest population, mostly affected by TB. The
lack of resources, such as lung biopsy samples, makes granuloma models potent tools
to study the biology of the MTB infection [46]. The granuloma holds the differentiation
of the two phases of TB, namely, active disease and latent sub-clinical infection [54, 59].
For active disease, high inflammation or tissue damage and enhanced IL-10 secretion
is recognized by different study groups [69]. In addition, how the different levels of
Th2, in particular IL-2, contribute to MTB pathogenesis is still controversial. The early
events post MTB infection are not well understood. This is a roadblock for identifying
target cells to be amplified to kill MTB before it proliferates, after the failure of the in-
nate immunity. In addition, switching time from innate to adaptive immunity is yet to
be delineated.
The most widely studied TB models, used to simulate human TB granuloma are the
guinea pig and mouse models [46], respectively. With the availability of uncostly re-
sources, non-human models remain relevant. In addition, Agent Based model (ABM)
capturing stochastic granuloma dynamics enlightened our understanding of cell migra-
tion and activities within the granuloma. This model considers interesting properties,
including granuloma dimension, cells in the granuloma, time-frame of cell interactions,
and signals received from cells in the granuloma [6]. Although other dynamics have not
been incorporated, simulation of T cell trafficking (time delay) and Naive CD4+ were
performed [6]. The results suggested that T cell trafficking was associated with high
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bacterial burden [6]. In addition, with the enhanced host-pathogen interaction, simula-
tion from ABM can be used to describe host cell components triggered for clearing MTB
load. The ABM showed stable granuloma is maintained by CD4+ T cells, possible by
employing TNF-α [6, 23]. Additionally, TNF-α dependent macrophage activation is not
efficient compared to IFN-α [6, 18]. Furthermore, there is a growing evidence suggesting
low levels of IL-10 correlate with TB containment [8, 11]. This mechanism was validated
by experimental studies [76].
Janis et al described factors attributed to cell dysfunction, and how TB latency is reached [14].
In addition, the cytotoxic cells and MTB evasion strategies were considered to be the ra-
tionale for cell dysfunction [12, 14]. The deficiency of IL-12 was associated with poor
functioning of Th1 and Th2 [14], respectively. Of these, several cytokines were consid-
ered discriminants of LTBI and active TB, namely. IL-12, IFN-γ and IL-10 [14]. This
findings were validated by the present experiments.
Lalita and colleagues used experiment from the zebrafish model to explore intriguing
TB granuloma dynamics [29]; in particular, the pathogenesis of MTB at the granuloma
stage [29]. Intuitively, intra-cellular life was analysed in accordance to how it switches
anatomy to evade anti-microbial molecules [29, 46]. Furthermore, it was delineated how
the granuloma benefit the bacteria more than the host [46, 59]. In addition, the factor al-
tering granuloma growth include, MTB dependent macrophage recruitment [29] and
infection of this recruited macrophages.
The summary in Table 2.1, shows the various TB approaches to understanding the hu-
man TB granuloma. Magombedze and Mulder reviewed and highlighted limitations
and key advancement in mathematics and computational modelling of host-MTB inter-
action [75]. In summary, most studies are restrained by the complexity of the interaction
between the host cell and the pathogen, which is fuelled by either the mutant MTB or
drug resistant MTB.
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Table 2.1: Granuloma models [75].
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To achieve global TB control, we need to review and investigate cell immunity to MTB
and comprehend various cells produced at different phases of TB. In addition, we need
to consider the variation between species, which may enhance the integration of diverse
experimental data from different species [75]. Understanding the functions of key cells
can aid in identifying the host-pathogen cell targets for potential TB vaccine and drug
development to improve TB control.





We develop a mathematical model that capture the interplay between three subsets of
the T lymphocytes (CD4+), namely. T helper type 0 (T0), T helper type 1 (T1) and T
helper type 2 (T2). These T cells are sensitised by infected macrophages for macrophage
activation, proliferation and other functions of protective immunity. In addition, we in-
spect three classes of macrophages, namely, rested macrophages (Mr),
infected macrophages (Mi) and activated macrophages (Ma) that interact within the host
environment. The signalling and inflammatory movement of this macrophages are fa-
cilitated by chemokines and cytokines. For this study, we only examine the movement
of cytokines of the type interleukin (IL) types 2, 4, 10 and 12, denoted by I2, I4, I10 and
I12, respectively. Additionally, we explore distinct roles of tumor necrosis factor-α (Iα)
and interferon-γ (Iγ) in host protection against MTB infection.
Mr uptake the extracellular bacterial load (B), to perform phagocytosis. Of these, Mi
perform the antigen presenting cells prompting T cells and other immune cells for cellu-
lar response against MTB infection [28]. We assume the released bacteria N, as a result
of Ma reaching multiplicity of infection. Furthermore, the class of Mi and Ma contain
intracellular bacteria. However, we only inspect the MTB to reproduce inside Mi at rate
αe. Of these, Mi uses α17 to induce T cell differentiation of both T0 into T1 and T0 into T2,
respectively. Thereafter, the T helper type 1 secretes larger amounts of I2, Iγ and Iα, for
cell death, macrophage activation and stabilizing the host environment. We allow T-cell
21
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proliferation by Ma.
To regulate this inflammatory processes, T2 cells are stimulated after T0 to T2 differen-
tiation for controlling inflammatory activities, producing regulatory cytokines I4 and
I10. This regulatory cytokines down-regulate the immune system by preventing over-
expression of cellular mediated immunity [10]. To investigate the balance between
pro-inflammatory and anti-inflammatory cellular responses controlled by regulatory T
(Treg) cell density, we inspect the capacity αtreg of I10 to promote T2 response. In ad-
dition, we examine the capacity (1− αtreg) of I10 to inhibit T1 response. Furthermore,
we observe this capacity affects T cell priming by Mi. The time delay πt is included to
investigate its effect on T cell differentiation.
Since the cytotoxicity of CD8+ T cells is inefficient in killing the MTB load [26]. We con-
sider T0 type cytokine I2, to facilitate cell death of Ma. All the cells are considered to
undergo programmed cell death or death due to aging. The ability to analyse the key
cytokines Iγ and I10, is crucial in the prevention of MTB persistence [76]. To capture and
mathematically describe the dynamics in Figure 3.1, we translate this dynamics into a
systems of differential equations below, taking into account the descriptions in the Ta-
ble 3.1 and Table 3.2 below. In addition, the pro-inflammatory and anti-inflammatory
cells dynamics are presented in Figure 3.2 and Figure 3.3, respectively.
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Figure 3.1: The diagram representing the cell to cell interaction of the protective immu-
nity against MTB infection.
The associated model variables and parameters are listed in Table 3.1 and Table 3.2, re-
spectively.
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Table 3.1: Description of variables and their measurements.
Variable Description Units
Mr density of rested macrophages cells/ml
Mi density of infected macrophages cells/ml
Ma density of activated macrophages cells/ml
Iγ concentration of interferon-gamma (IFN-γ) pg/ml
I2 concentration of interleukin-2 (IL-2) pg/ml
I4 concentration of interleukin-2 (IL-4) pg/ml
Iα concentration of tumor necrosis factor-α (TNF-α) pg/ml
I10 concentration of interleukin-10 (IL-10) pg/ml
I12 concentration of interleukin-12 (IL-12) pg/ml
T0 concentration of T-Helper Type 0 (Th0) pg/ml
T1 concentration of T-Helper Type 1 (Th1) pg/ml
T2 concentration of T-Helper Type 2 (Th2) pg/ml
B bacterial load of MTB pg/ml
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Table 3.2: Description of parameters and their units.
Parameter Description Units
λ0 source of T0 cells/ml/day
λr source of resident macrophages from monocytes cells/ml/day
α4 inhibition rate of the Iα and Ma proliferation by I4 pg/ cell day
α10 the ability of the B to subvert I10 capacity pg/ cell day
α12 production rate of I12 by Ma pg/ cell day
α13 production rate of Tα by T1 pg/cell day
α15 production rate of I4 by T2 pg/cell day
α16 production rate of I2 by T1 pg/cell day
α17 priming rate of T0 by Mi ml/cell/day
α24 proliferation rate by Ma 1/day
α25 inhibition rate of Iγ response by I10 1/day
αb priming rate of T2 response by B 1/day
αB growth rate of B 1/day
αi macrophage activation rate for Mi due to Iγ ml/cell/day
αk inhibition rate of I12 production by B using I10 1/day
αr macrophage infection rate of Mi due to B ml/cell/day
βi the capacity of Mi to reduce the bacterial load of B cell−1
β10 the capacity of T0 to differentiate pg/ cell day
αtreg the capacity of the I10 to promote T2 response pg/ cell day
1− αtreg the capacity of the I10 to inhibit T1 response pg/ cell day
µ0 per capita death rate of T0 due to apoptosis 1/day
µ1 per capita death rate of T1 due to apoptosis 1/day
µ2 per capita death rate of T2 due to apoptosis 1/day
µa per capita death rate of Ma due to apoptosis 1/day
µg per capita death rate of Ma due to bursting 1/day
µm per capita death rate of Ma due to I2 1/day
µi per capita death rate of Mi due to apoptosis 1/day
µr per capita death rate of Mr due to apoptosis 1/day
µB per capita death rate of B 1/day
dγ degradation rate of Iγ 1/ day
d2 degradation rate of I2 1/ day
d4 degradation rate of I4 1/ day
dα degradation rate of Tα 1/day
d10 degradation rate of I10 1/ day
d12 degradation rate of I12 1/ day
πt time delay of T0 priming by Mi
N multiplicity of infection (MOI) by Ma
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In the next section, we characterize the cells into pro-inflammatory and anti-inflammatory




We consider three distinct subsets of macrophages, namely rested macrophages, Mr,
infected, Mi, and activated macrophages, Ma. Of these, the macrophage population is
defined as M = Mr + Mi + Ma. Mr are macrophages waiting for chemokine signals to
phagocyte the MTB load [20]. Many human and non-human models have demonstrated
that Mr differentiate as a result of monocytes [17]. Moreover, Mr are one of the prime
target of the extracellular bacteria, due to their inefficiency of cytotoxic activities [14].
Moreover, after Mr engulf B, they become infected thus moving from Mr into Mi [8].
T1 secrete larger concentration of Iγ for activation of Mi, which become Ma [10]. Studies
have shown that Ma can effectively eliminate other intracellular microbes [14, 21]. For
MTB, it has been shown that Ma are potent in killing substantial MTB load [28]. We con-
sider I2 to activate and prepare Ma for cell death [20]. However, they are unable to clear
the entire MTB load [27]. As a result, we include bi-fatality of Ma, death due to apoptosis
and death due to bursting. Janis.E et al [14], strongly suggested T1 response is down-
regulated by several T2 type cytokines, specifically, the frequently studied regulatory
cytokine, I10 [22]. However, for Ma, we only consider I4 to perform anti-inflammatory
activities, merely blocking the process of proliferation. After phagolysosome collapse,
Ma burst as a result of reaching maximal capacity of infection (MOI), leading to evasion
of the intracellular MTB [9]. This released MTB by Ma is denoted by N.
Rested Macrophages (Mr)
The dynamics of Mr incorporates the mechanism of MTB uptake. This rested macrophages
are differentiated from monocytes [17]. For this class of macrophages, we simply track
the infection rate as a result of phagocytosis. The efficacy of the phagocytosis depends
on the multiplicity of infection (MOI) [89] and the influence of toll-like receptors (TLR)
signal pathway [88]. In addition, we consider the programmed cell death.
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To formulate the equation for the rested macrophages, we represent the monocytes as
the source λr, of rested macrophages Mr. Moreover, we denote the infection rate of Mr




= λr − αr MrB− µr Mr. (3.2.1)
Infected Macrophages (Mi)
After bacterial contagion Mr transform to class of infected macrophages (Mi). This class
of macrophages prime T0 for T0 into T1 differentiation. This leads to inducement of
cytokines by T1, including Iγ which prepare infected macrophages for apoptosis [10].
However, this process is down-regulated by the well-known anti-inflammatory cytokine
I10 [76]. We assume no extracellular MTB release after the transformation from rested to
infected macrophages, we only consider N, extracellular MTB after bursting of activated
macrophages.
From the description above, we write the equation of Mi. Since the intracellular B within
Mi is able to be dormant for a particular time [26]. We suppose Mi allows the B to repli-
cate intra-cellularly. However, for the equation of Mi we only observe the priming of T
cells with time delay, represented by the term α17πt MiT0. Furthermore, Mi prime T cell
differentiation at rate α17, to be activated by Iγ at rate αi. In addition, µi represent death
rate due to apoptosis or aging [21], so that the equation of Mi becomes:
dMi
dt
= αr MrB− αi Mi Iγ + α17πt MiT0 − µi Mi. (3.2.2)
Activated Macrophages (Ma)
We present the class of activated macrophages, the key determinant of MTB dissemina-
tion. This class of macrophages arises from priming of T cells by Mi. This leads to in-
ducement and triggering of the immune cells, such as the activation of Mi by interferon-
γ. Furthermore, the Ma secrete I12 for T cell proliferation. This process promote the
Stellenbosch University  https://scholar.sun.ac.za
Chapter 3. Tuberculosis micro-environment dynamics model 28
killing efficacy of the I2, the cytokine facilitating cell death. Moreover, over-expression
of the immune response can provoke tissue damage or adverse reactions. Of these, the
anti-inflammatory cytokines I10 and Iα prevent over-expression by blocking several ac-
tivities [9, 20]. For Ma, the MTB bacteria manipulate I10 to block T cells proliferation by
Ma.
To capture the dynamics of Ma, we consider key basic activities; bursting of Ma pre-
sented by µg Ma Iα. Iα is very effective in promoting distinct anti-mycobacterial activities
including, macrophage and lymphocytes recruitment to achieve latency [21]. In this
study, we consider Iα to facilitate the process of alleviating bursting of Ma. Additionally,
we consider bi-fatality terms for Ma, death due to bursting of Ma, represented by µa,
and the death µm administered by I2. We deduce the concentration of Ma decrease as
a result of performing the process of proliferation, explained by the term α12 Ma1+αkBI10 . It is
assumed the population of B only increases inside the Ma, so that Ma equation becomes
dMa
dt




3.2.2 T helper type 0 (Th0) cell (T0)
T lymphocytes are well recognized as the mediators in cellular response to MTB infec-
tion and extraneous infectious diseases [15]. We have distinct array of T lymphocytes
including CD4+ and CD8+, facilitating defence against infections and killing of infected
cells [20], respectively. The T helper type 1 (Th1) and T helper type 2 (Th2) cells originate
from undifferentiated Th0 with a source λ0. Recently, the role of CD8+ in performing
cytotoxic activities in MTB infection, remains controversial. The LTBI phase exploit im-
mune potent to efficiently kill and clear out the pathogen. Recent findings indicate MTB
exhibits properties to survive phagolysosome fusion and granulysin [11]. Since it has
been extensively studied that cytotoxic effects of CD8+ are unable to clear the tubercu-
lous bacilli [11]. As a result, we dont consider Cytotoxic T cells (CTL) from the CD8+ T
cells subsets performing granulysin or killing activity.
T0 are synthesized by infected macrophages, through a process called T cell priming.
This is a very crucial component of initiating host defence against MTB infection. It
was hypothesized that intracellular MTB use the Toll-like receptors to interrupt both
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the innate and adaptive immunity [50]. This mechanism includes manipulating the
functioning of APC, which adversely affects switching from innate to adaptive immu-
nity [74]. The roles T0 can be categorized according to the pro-inflammatory and anti-
inflammatory assignment. We described strategies employed by activated macrophages
e to trigger T-cell mediated immunity.
T0 originates from the thymus, naive T helper cells are then recruited to the site of infec-
tion to perform distinct anti-microbial duties [50]. We assume T cells have a source λ0
from the naive T helper cells and die at rate µ0. The fifth term represents T0 proliferation
that is induced by I12 at rate α24. However, this process is regulated by I4 at rate α4.
We include the priming term α17MiT0 without delay. However, we explore how the ca-
pacity of regulatory cytokine I10 to inhibit the differentiation of T0 into T1 influences the
presentation of MTB by Mi. This is represented by the term (1− αtreg)β10MiT0. Lastly,
we denote, µ0, death rate of T0. Then we have,
dT0
dt




− (1− αtreg)β10MiT0 −
α24T0 I12
1 + α4 I4
− αbBT0 − µ0T0.
(3.2.4)
3.2.3 Intracellular MTB (B)
We formulate and describe an equation explaining strategies used by MTB to trigger and
elude the robust cellular response. The ability of the pathogen to colonize the host envi-
ronment is a setback in the enhancement of the understanding of the MTB pathogenesis.
After MTB infection, cultured filtrate proteins (CFP) including, ESAT-6 and Ag85B are
the first MTB proteins to be recognized [74], this CFP escalates the complexity of the
MTB pathogenesis. Of these, observation from mice models confirmed results of dead
bacteria secreting proteins larger amounts of Ag85B protein [74]. The pathogenesis of
MTB is greatly determined by the time efficacy of the immune response after aerosol in-
fection with MTB [9, 50]. Specifically, late triggering of the innate immunity makes MTB
disperse into other organs of the host [23] and blood stream for progression of active
disease. To enrich our understanding of cell mediated response to MTB, we integrate
these different interactions into the dynamics of MTB equation.
The bacterial load, B, which expound the disease outcome greatly depends on the growth
rate. To capture this process, we consider the term αeB. In the host-MTB battle, observa-
tions suggest MTB uses fatty acids and other lipids as a mechanism for survival [75]. Of
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these, we consider them as the other source of emphMTB growth. Moreover, the term
µgNMa Iα characterises the number of released bacteria, N, after bursting of Ma, which
is due to the Ma reaching the maximal capacity of infection (MOI). This phenomenon
is administered by Iα at the rate µg. Since we do not consider extracellular B, the term
µgNMa Iα do not lead to new MTB infection. It only increase the bacterial load, B, that
will be engulfed by Mr. The programmed cell death and the death due to the inability
of the MTB pathogen to adapt the host environment is captured by the term µBB. Then
the equation of B is given by:
dB
dt
= αeB + βi Mi + µgNMa Iα − µBB. (3.2.5)
3.2.4 Pro-inflammatory cells
Figure 3.2: The pro-inflammatory cells.
The biology and formulation of the pro-inflammatory cell equations are elucidated be-
low.
T helper type 1 (Th1) cell (T1)
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Th1 cells are the most important and effective subset of T0 cells, which may facilitate
pathology of viruses (i.e., HIV) and pathogens (i.e., MTB). The pathways in which dis-
tinct host cells are induced and expressed by different arrays of cells, is still to be elu-
cidated. This hurdle is exacerbated by various factors, including how T cell response
differs in early phase of the MTB infection and also in acute TB phase, respectively.
Moreover, very few studies attempted to assimilate different experimental results. In
this study, we inspect the key duties performed by T1, during MTB infection. This may
provide unrevealed pathways that may provide insights to the strong cellular immunity
of MTB.
Mi are very useful in presenting MTB antigen prematurely before it manifests in the host
domain [22]. Additionally, Mi are able to localize the pathogen and stimulate various
immune cells. Thus, navigating the process of switching from innate to adaptive immu-
nity [13, 25]. We suppose that all the presentation of MTB is administered by Mi.
We formulate the equation that explain the dynamics of T1 over time. The term α24T0 I121+α4 I4
represents the rate at which T0 proliferate by interacting with I12. This process is inhib-
ited by I4 at rate α4. The term α17(1− πt)MiT0 elucidate how time delay affect priming
of T cells by Mi. In addition, we include the death term µ1T1. The remaining three
terms tracks the production of pro-inflammatory cytokines ,Iγ, Iα and I2 with the pro-
duction rates given by α1, α13 and α16, respectively. However, this productions are down-
regulated by regulatory cytokines I4 and I10. For Iα, we have high down regulation from
both the regulatory cytokines. The inhibition rates are α4 and α25, respectively. For I2
and Iγ, the inhibition rates are α11 and α25, respectively. Then the equation becomes
dT1
dt
= α17(1− πt)MiT0 −
α1T1
1 + α25 I10
− α13T1
1 + α25 I10 + α4 I4
− α16T1
1 + α25 I10
+
α24T0 I12




The cytokines are very important type of proteins that are secreted by distinct cells of
the immune cells. The interaction of cytokines with chemokines and T cells is vital
for a stable and functional immune response to MTB and other infections [65, 76]. In
this study, we consider Th1-type cytokines I2, Iα and Iγ, respectively. In addition, anti-
inflammatory activities will be performed by both T2 and Treg cell cytokines I4 and I10,
respectively. Additionally, although I2 plays a critical role in T-cell proliferation, elimi-
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nating infected cells and also facilitating the movement of cell to cell interaction [10]. In
this research, we observe its effect on preparing MTB infected cells to die.
The protective roles of Iγ and I10 have been well studied using both animal and hu-
man dummies [76, 84]. During early stages of TB, T1 produces larger amounts of Iγ
for macrophage activation [9]. Moreover, I10 regulate Iγ response to alleviate over-
expression of the immune system [15]. Regulating on-going immune system is essential
to counteract immuno-suppressive effects.
To analyse the dynamics of immune system, we introduce systems of non-linear differ-
ential equations, which includes production of specific cytokine by the associated cells
and the depletion rates [16]. Although, cytokines are produced by distinct cells, the
depletion and secretion solely rely on the phenotype of the cells prompting pertuba-
tions [16].
Interleukin-12 (I12)
I12 is secreted by Ma for T cell proliferation that stimulate T cell activation [10]. How-
ever, B manipulate I10 to halt this process [76]. We observe this mechanism at rate, α12,
and the inhibition rate αk, the term αkBI10 clearly illustrate this mechanism. Since cells






− d12 I12. (3.2.7)
Interleukin-2 (I2)
I2 is a vital Th1-type cytokine facilitating cell death and other biological functions [24].
In this study, we observe the effect of I2 in preparing Ma for death at rate α16. This pro-
cess is down-regulated by the I10 at rate α25, including the depletion rate d2, the equation
becomes,
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1 + α25 I10
− d2 I2. (3.2.8)
Tumour Necrosis Factor-α (Iα)
Iα is essential for granuloma formation and for restraining the MTB dissemination [59,
66]. Iα has been extensively studied, enhanced Iα is associated with host resistance to
MTB pathogenesis [22]. Studies on Mice with low-elevated Iα showed progression to
fatal TB disease [14, 19]. Moreover, the observed patients with low concentration of Iα
exhibited multibacillary lesions [23]. It remains unknown wherefore high and low ele-
vated concentration contribute to progression to active TB.
This T1 type cytokine, Iα, is produced by both lymphocytes and alveolar macrophages [23].
However, production by alveolar macrophages poses a challenge to host resistance to
MTB, causing inflammation and tissue damage [20]. T1 produces Iα to promote phago-
cytosis process in Ma and stabilize the granuloma. To alleviate inflammation, we in-
corporate both I4 and I10 to regulate the Iα response at rates α4 and α25, respectively.





1 + α25 I10 + α4 I4
− dα Iα. (3.2.9)
Interferon-γ (Iγ)
Interferon-γ is significantly recognized to be a cornerstone cytokine in protection against
intracellular pathogens, in particular MTB [22]. In addition, expression of Iγ in MTB in-
fection is well investigated and addressed by different study groups [54, 62, 84]. How-
ever, little mechanisms are addressed on its potent at granuloma stage. Iγ potency was
investigated during both active TB and LTBI [74]. For both, active TB and LTBI, Iα and
Iγ were highly expressed in both active TB and LTBI [26, 28]. Moreover, the role of Iγ on
macrophage activation is very crucial in preventing intracellular survival of MTB [9].
In this study, we observe how its production rate α1 from T1, which is inversely influ-
enced by the concentrations of I10. Thus, since I10 blocks T1 response [76], we include
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1 + α25 I10
− dγ Iγ. (3.2.10)
All of the rates with α indexes represent the production rate by a specific cell type and
di denote the depletion of the cells.
3.2.6 Anti-inflammatory cells
Figure 3.3: The anti-inflammatory cells.
T helper type 2 (Th2) cell (T2)
We consider T0 as the source of T2, since it depends on the capacity of T0 to differentiate.
Furthermore, since B is able to exploit the T2 response, we investigate how this activity
impact cellular immunity of MTB. The formulation of T2 equation is described below.
T2 produces I4 to perform distinct anti-inflammatory activities. This includes blockage
of T0 into T1 differentiation and regulating the activities of both Ma and Iα. The term
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αbBT0 account for the mechanism in which MTB exhibit to promote differentiation from
T0 into T2. We include the death term µ2T2. The equation of T2 is given by
dT2
dt
= αbBT0 − α15T2 I10 − µ2T2. (3.2.11)
3.2.7 Anti-inflammatory cytokine: Interleukin-4 (I4)
The role of I4 in MTB infection is debatable and still not clearly understood. Recently, I4
has been appreciated to be T2 type cytokine. Its expression during two phases of active
TB and LTBI remain to be elucidated [27].
We use the fact that I4 is secreted by T2 and regulated by I10 with the depletion term
d4 I4, including the production rate α15, we have
dI4
dt
= α15T2 I10 − d4 I4. (3.2.12)
3.2.8 Regulatory cytokine: Interleukin-10 (I10)
I10 was first recognized and described as T2 type cytokine, until extensive reviews from
several authors disputed this findings [24]. Although distinct cells can produce it, re-
cently, significant evidence suggest that Treg cells are the main producers of I10 [22].
However, its protective effects against TB remain unclear. It will be interesting to inves-
tigate unknown mechanisms of I10. Since it is involved in many biological features of
anti-inflammatory response. For this study, we observe its effects on halting and pro-
moting several biological processes. This description is explained below.
We consider Treg cells as the producer with the depletion term d10 I10. However, Treg
cells are not included in our state variables. We consider the capacity αtreg of the I10
to promote T2 response. The term αtregα10BT0 represents the ability of the pathogen
to subvert the capacity 0 ≤ αtreg ≤ 1 for I10, to regulate T0 response at rate α10. In
addition, we consider the capacity (1 − αtreg) of I10 to inhibit T1 response. The term
(1 − αtreg)β10MiT0 track how this capacity affects T cells priming. The parameter β10
delineates the capacity of T cells to differentiate after being primed by Mi. Then we
have:
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dI10
dt
= αtregα10BT0 + (1− αtreg)β10MiT0 − d10 I10. (3.2.13)
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3.2.9 Mathematical representation of the model
The system of differential equations for the host immune cell-MTB dynamics are given
by:
dMr
dt = λr − αr MrB− µr Mr.
dMi
dt = αr MrB− αi Mi Iγ + α17πt MiT0 − µi Mi.
dMa





































− (1− αtreg)β10MiT0 − α24T0 I121+α4 I4 − αbBT0 − µ0T0.
dT1
dt = α17(1− πt)MiT0 −
α1T1
1+α25 I10
− α13T11+α25 I10+α4 I4 −
α16T1
1+α25 I10
+ α24T0 I121+α4 I4 − µ1T1.
dT2
dt = αbBT0 − α15T2 I10 − µ2T2.
dB
dt = αeB + βi Mi + µgNMa Iα − µBB.
(3.2.14)
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The initial conditions of the system in (3.2.14) are given by:
Mr(0) = M0, Mi(0) = 0, Ma(0) = 0, Iγ(0) = 0, I2(0) = 0, I4(0) = 0, Iα(0) = 0, I10(0) = 0,
I12(0) = 0, T0(0) = τ0, T1(0) = 0, T2(0) = 0, B(0) = B0 with M0 > 0, τ0 > 0 and
B0 ≥ 0.
To observe the host cell response to the initial MTB infection B0. The behaviour of the
system in (3.2.14) will be tracked over time.
3.3 Model analysis
The system of differential equations in (3.2.14) can be shortly written as the following
initial value problem (IVP):





Mr(t), Mi(t), Ma(t), I2(t), I4(t), I10(t), I12(t), Iα(t), Iγ(t), T0(t), T1(t), T2(t), B(t)
)
,
x0 = (M0, 0, 0, 0, 0, 0, 0, 0, 0, τ0, 0, 0, B0) .
and
f : R+ ×R13+ −→ R13+
(t, x) 7−→ f (t, x) = ( f1, f2, f3, f4, f5, f6, f7, f8, f9, f10, f11, f12, f13) .
with
f1 = λr − αr MrB− µr Mr.
f2 = αr MrB− αi Mi Iγ + α17πt MiT0 − µi Mi.










1 + α25 I10
− d2 I2.
f6 = α15T2 I10 − d4 I4.
f7 =
α13T1
1 + α25 I10 + α4 I4
− dα Iα.
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− (1− αtreg)β10MiT0 −
α24T0 I12
1 + α4 I4
− αbBT0 − µ0T0.
f11 = α17(1− πt)MiT0 −
α1T1
1 + α25 I10
− α13T1
1 + α25 I10 + α4 I4
− α16T1
1 + α25 I10
+
α24T0 I12
1 + α4 I4
− µ1T1.
f12 = αbBT0 − α15T2 I10 − µ2T2.
f13 = αeB + βi Mi + µgNMa Iα − µBB.
Here we assume that x and f are non-negative functions, we are dealing with (cell)
populations. Except explicitly expressed x(t), is a set here for the rest of this thesis.
Given U an open set of Rn+1, we denote C(U, Rn), the set of continuous functions from
U to I and C1(U, Rn), the set of differentiable functions from U to Rn. C(I) and C1(I),
for an interval I ⊂ R, denote the set of continuous and derivable real-valued functions,
respectively.
3.3.1 Existence and uniqueness to the problem (3.3)
Theorem 3.3.1. IVP in (3.3) or (3.2.14) has a unique solution for all t ∈ R+, satisfying the
initial condition x(0) = x0.
In fact, this is directly derived from the Picard Lindelöf theorem [94], which is stated as
follows:
Theorem 3.3.2. (Picard Lindelöf).
Let f ∈ C(U, Rn) and consider the following IVP:
x′(t) = f (t, x),
x(t0) = x0,
if f is Lipschitz continuous in x and uniformly continuous in t, then the IVP above has a unique
solution x(t) ∈ C1 ((t0 − ε, t0 + ε) , Rn), for some real value ε > 0.
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Note that for IVP in (3.3) and (3.2.14) f ∈ C1(R+ × R13+ , R13+ ), i.e., f is differentiable,
which implies that f is Lipschitz continuous in x and uniformly continuous with respect
to t [94].
3.3.2 Positivity of solutions.
Lemma 3.3.3. The following first order non-homogeneous linear equation:
x′(t)+p(t)x(t) = q(t),
x(t0) = x0, (3.3.2)
where p, q ∈ C ((t0 − ε, t0 + ε)) for some real ε > 0, has a unique solution for all t ∈
















The solution is given by




It is worth noting that if q(t) = 0 for all t, then we obtain the first order homogeneous
linear equation with solution x(t) = x0e−F(t).
We use the above Lemma 3.3.3 and initial conditions to show that regardless of cell de-
ficiency or exhaustion, our system (3.2.14) remains positive for all time (i.e., t ≥ 0).
Lemma 3.3.4. In case of the MTB infection, all state variables in (3.2.14) are positive, i.e.,
Mr(t) ≥ 0, Mi(t) ≥ 0, Ma(t) ≥ 0, T0(t) ≥ 0, T1(t) ≥ 0, T2(t) ≥ 0 and B(t) ≥ 0
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, then their solutions remain non-negative for all t ≥ 0.
It is worth noting that for any living host, it is biologically rational to assume that T0(t) ≥
0 and Mr(t) ≥ 0. Here we show that biological rational still holds for the system (3.2.14).
Furthermore, we are assuming the existence of the MTB infection, i.e., B(t) ≥ 0, which
may be 0 in case the host successfully clears the infection.
So, for the rested macrophages we have
dMr
dt





≥ − (µr + αrB) dt. (3.3.4)
Then, we integrate the above equation (3.3.4) to obtain











0B(s)ds) ≥ 0, since Mr(0) ≥ 0.
Hence, Mr(t) is always positive for all t.
Similarly for infected macrophages, we have that,
dMi
dt
≥ (αi Iγ(t) + α17πtT0(t) + µi) Mi(t).
Dividing both sides by Mi(t), we obtain
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dMi
Mi
≥ (α17πtT0(t)− αi Iγ(t)− µi) dt. (3.3.5)











Therefore, Mi(t) is always positive for all t.













Thus, Ma(t) ≥ 0 for all t.





1 + α25 I10
− dγ Iγ ≥ −dγ Iγ.
Iγ(t) ≥ Iγ(0)e−dγt > 0, where Iγ(0) ≥ 0.
Similarly, for the I2 we have
I2(t) ≥ I2(0)e−d2t > 0, where I2(0) ≥ 0.
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Furthermore, we integrate equations (3.2.7) and (3.2.9) to obtain,
I12(t) ≥ I12(0)e−d12t > 0, where I12(0) ≥ 0.
Then for the Iα we have,
Iα(t) ≥ Iα(0)e−dαt > 0, where Iα(0) ≥ 0.
Then for the regulatory cytokines I4 and I10 we integrate equations (3.2.12) and (3.2.13),
to obtain
I4(t) ≥ I4(0)e−d4t > 0, where I4(0) ≥ 0.
For the I10, we have
I10(t) ≥ I10(0)e−d10t > 0, where I10(0) ≥ 0.
dT0
dt




− (1− αtreg)β10MiT0 −
α24T0 I12
1 + α4 I4







+ (1− αtreg)β10Mi +
α24 I12
1 + α4 I4
+ αbB + µ0
)
T0. (3.3.6)
we simplify equation (3.3.6), such that
K1(t) =
α24 I12
1 + α4 I4
.
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Hence, T0(t) ≥ 0 for all t.
For T1, we consider the following inequality
dT1
dt
= α17(1− πt)MiT0 −
α1T1
1 + α25 I10
− α13T1
1 + α25 I10 + α4 I4
− α16T1
1 + α25 I10
+
α24T0 I12
1 + α4 I4
− µ1T1.




1 + α25 I10
, K3(t) =
α13




1 + α25 I10
.











Therefore, T1(t) is always positive for all t.
For T2, we consider the equation below
dT2
dt
= αbBT0 − α15T2 I10 − µ2T2.
≥ − (α15 I10(t) + µ2) T2. (3.3.8)
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The integration of the above equation (3.3.8) is given by
T2(t) ≥ T2(0)e−(α15
∫ t
0I10(s)ds+µ2t) ≥ 0, where T2(0) ≥ 0.
Hence, T2(t) is always positive for all t.
Lastly, for the bacteria, B, we consider the equations below
dB
dt
= αeB + βi Mi + µgNMa Iα − µBB.
≥ − (µB − αe) B positive if µB > αe. (3.3.9)
Therefore, integrating the above equation (3.3.9), we obtain
B(t) ≥ B(0)e−t(µB−αe) ≥ 0, since B(0) ≥ 0.
Thus, B(t) ≥ 0 for all t.
Therefore, our state variables are all positive. This implies the solution of the sys-
tem (3.2.14) will be non-negative for all t ≥ 0.
Next, we want to show that all the state variables of the system of differential equations
in (3.2.14) are bounded.
3.3.3 Feasible region
We now consider a positively invariant region, a set showing boundedness of the sys-
tem (3.2.14). The set defined in lemma 3.3.2 with lower bound 0 and upper bound de-
fined by macrophage, T cell and cytokine dynamics equations.
Lemma 3.3.5. The set of solution of the system of differential equations in (3.2.14) is given by:
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Ω =
{
x(t) ∈ R13+ : Mr(t), Mi(t), Ma(t) ≤ A;
Iγ(t) ≤ F, I2 ≤ G, Iα(t) ≤ D, I12(t) ≤ H, I4(t) ≤ ξ, I10(t) ≤ ϕ; (3.3.10)
T0(t), T1(t), T2(t) ≤ C; B(t) ≤ E
}
To show that all the solution originating in Ω, are restricted in the set Ω. We prove
the unique boundedness of host cells equations in (3.2.14), according to the subsets,
macrophages, T cells and cytokines, respectively.
We have shown in Lemma 3.3.2 that all states variables are positive. We now show that
all the states variables of the system (3.2.14) are bounded, i.e., the set Ω is bounded.
To proceed, we first let

















≤ λr − µr Mr − µi Mi − µa Ma.
≤ λr − µ (Mr + Mi + Ma)
≤ λr − uM.
Where
µ = min{µr, µi, µa}
Integrating equation (3.3.3) with respect to t. We get that
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For the T cells, we first simplify below.












≤ λ0 − µ0T0 − µ1T1 − µ2T2
= λ0 − µ∗ (T0 + T1 + T2)
= λ0 − µ∗T. (3.3.11)
With µ∗ = min {µ0, µ1, µ2}.
Knowing that T is a positive function and integrating equation (3.3.11), we obtain:
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Finally
0 ≤ T(t) ≤ λ0
µ∗
= C. (3.3.12)
For the Iα, we know that
0 <
1





≤ α13T1(1)− dα Iα.
Using the relation (3.3.3), it follows that
dIα
dt
≤ α13C− dα Iα.
Since Iα is a positive function of time and integrating each side of the inequality, we ob-
tain:















For the bacteria, we have the equation below:
dB
dt
= αeB + βi Mi + µgNMa Iα − µBB.
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Since M(t) ≤ A and Iα(t) ≤ D, we have:
dB
dt






Integrating equation (3.3.13) over the interval [0, t) yield,
















Taking the limit as t tends to infinity we have,



























To show the boundedness of the cytokines. We first show that IL-10 is bounded. Con-
sider the equation below,
dI10
dt
= αtregα10BT0 + (1− αtreg)β10MiT0 − d10 I10. (3.3.14)
We know that
Mi(t) ≤ A, T0(t) ≤ C and B(t) ≤ E. (3.3.15)
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After integrating equation (3.3.14) and considering the expressions in (3.3.15). We ob-
tain:

































e−d10t → 0 as t→ ∞.
Thus, the boundedness of IL-10 is given by:










We proceed by showing that IL-4 is bounded. Since we have proven that B(t) ≤ E and
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The boundedness of the pro-inflammatory cytokines, IFN-γ, IL-2 and IL-12 are shown











d2 (1 + α25 ϕ)
= G.





d12 (1 + αk ϕE)
= H.




x(t) ∈ R13+ : Mr(t), Mi(t), Ma(t) ≤ A;
Iγ(t) ≤ F, I2 ≤ G, Iα(t) ≤ D, I12(t) ≤ H, I4(t) ≤ ξ, I10(t) ≤ ϕ; (3.3.16)
T0(t), T1(t), T2(t) ≤ C; B(t) ≤ E.
}
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d12 (1 + αk ϕE)
.
Therefore, the system in (3.2.14) is bounded by the region Ω. And for all t positive, the
solutions will remain in Ω.
3.3.4 MTB infection-free equilibrium point
Definition 3.3.6. The MTB infection-free equilibria is a point where the bacteria is not present
in the system [70].
We now consider a state where the MTB load is cleared from the system (3.2.14). Since
there is no MTB infection, B(t) = 0. This leads to the termination of processes, including
uptake of the the bacteria and macrophage activation, respectively. This set the dynam-
ics of the cells Mi(t) and Ma(t) to MTB free state, i.e., Mi(t) = Ma(t) = 0. We remain
with the reduced system of Mr(t) and CD4+ T cells subsets, T0, T1, and T2, respectively.
This resulting subsets of equations are given by:
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dMr
dt
= λr − µr Mr.
dT0
dt
= λ0 − µ0T0. (3.3.17)
dT1
dt




We now equate and solve the above system (3.3.4) to zero so that,
λr − µr Mr = 0
λ0 − µ0T0 = 0
−(α1 + α13 + α16 + µ1)T1 = 0
−µ2T2 = 0




Thus, the MTB infection free equilibrium point is given by:
(






, 0, 0, 0, 0, 0, 0, 0, 0,
λ0
µ0
, 0, 0, 0
)
From the above E0, we can see the MTB infection free equilibrium (E0) is maintained by
both rested macrophages (Mr) and T helper type 0 cells (T0). For Mr, the ratio λrµr rep-
resents the proportions of the recruited rested macrophages to death rate. In addition,
our system 3.2.14 solely rely on the T helper type 0 cell growth factor, λ0µ0 . The existence
of Mr and T0 at E0 shows that the model explains a state where the immune system is
robust to detect and contain the new MTB infection.
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3.3.5 Endemic equilibrium
We now consider a state where the MTB infection cannot be eradicated from the host.
This can be regarded as a condition under which the host reach LTBI, which is an equi-
librium or a state of non-replicating or dormant MTB [75]. To compute the endemic
equilibrium, we employ R to set the system (3.2.14) to zero and solve for the state vari-









































B∗T∗0 (Ψ3−Ψ4 M∗i )
)
−Ψ1M∗i T∗1






1 + α25 I∗10














1 + αkB∗ I∗10









µ0 + Ψ7M∗a +
(










µ1 − Ψ101+Ψ9(Ψ6B∗T∗0−Ψ4 M∗i T∗0 )
, T∗2 = αbB
∗T∗0 µ2 − (Ψ6B∗ + (β10 −Ψ12M∗i T∗0 ))Ψ11,
B∗ =
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, Ψ6 = α10αt, Ψ7 =
α12α24
d12




Ψ10 = (α1 + α13 + α16) , Ψ11 = α15β10, Ψ12 = αtβ10.
3.3.6 The basic reproduction number
Definition 3.3.7. The reproduction number R0, is the number of secondary infections caused
in the population, by a single infected individual [52] at an infection free equilibrium.
Experimental studies showed that each macrophage can engulf approximately 5 MTB
load [86]. Of these, we incorporate this observation and define R0 as the whole number
of secondary infected macrophages (Mi), that is caused by about 5 MTB load [19, 20].
Here, we use the next generation method to compute the R0.
Let
• Fc(x) denotes the rate of new infected macrophages Mi in the cell.
• V+c (x) denotes the rate at which MTB infection is transferred within a cell.
• V−c (x) denotes a cell able to transmit infection leaves the host system.
Therefore, the MTB infection system can be defined as,
dxc
dt
= Fc(x)− Vc(x). (3.3.18)
Where Vc(x) = V+c (x)− V−c (x), and c = {1, . . . , k}, are cells capable of infecting other
cells. For the above system (3.3.18), it is assumed that Fc(x) and Vc(x) are both differ-
entiable functions [70]. The extend of the system in (3.3.18) at MTB infection free state,
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With 1 ≤ c and j ≤ k. We obtain R0 from the eigenvalues of the resulting matrix FV−1.




= αeB + βi Mi + µgNMa Iα − µBB,
dMi
dt











αeB + βi Mi + µgNMa Iγ
αr MrB
0
 and V =

µBB
(αi Iγ + µi − α17πtT0) Mi(
µa + µm I2 + µg Iα + α121+αkBI10
)
Ma − αi Mi Iγ

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0 0 µa + α12










Therefore, we obtain the next generation matrix K, as follows:















µBµr (µ0µi − α17λ0πt)
= 0 (3.3.20)
For simplicity, we condense the equation (3.3.20) such that:
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χ2 − χω− σ = 0 (3.3.21)











































represent the growth factor of rested macrophages after MTB infection.
µ0
(µ0µi − α17λ0πt)
represent T cell growth factor after being primed by infected
macrophages.
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Since R0 is the largest eigenvalue of the matrix, K or the spectral radius of the above
matrix, K.






The above expression (3.3.22) suggests that our R0 depends greatly on the growth fac-
tors of Mr and T0, respectively. In addition, the priming rate with the delay plays an
important role in determining the outcome of the MTB infection. This supports the fact
that for strong cellular immunity, priming rate with low time delay, T cell activation and
macrophage recruitment are the keystone in facilitating and maintaining of the immune
system.
In the next section 3.3.7.1 and section 3.3.7.2, we use the threshold of the reproductive
number, R0 < 1. To analyse the stability of the system (3.2.14).
3.3.7 Stability of the infection-free equilibrium
3.3.7.1 Local stability of the infection-free equilibrium
To analyse local stability of the system (3.2.14). We show that if the eigenvalues of the
Jacobian matrix have negative real parts. Therefore, the MTB infection free equilibrium,
E0, is locally asymptotically stable, i.e, Re(λk) < 0 and R0 < 1 [93].
Where
{λk ∈ C|k = 1, . . . , 13}
.
Consider the MTB infection free equilibrium Jacobian Matrix
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J(E0) =

−µr 0 0 0 0 0 0 0 0 0 0 −αrλrµr 0




0 0 − (α12 + µa) 0 0 0 0 0 0 0 0 0 0
0 0 0 −dγ 0 0 0 α11 0 0 0 0 0
0 0 0 0 −d2 0 0 α16 0 0 0 0 0
0 0 0 0 0 −dα 0 α13 0 0 0 0 0
0 0 α12 0 0 0 −d12 0 0 0 0 0 0
0 C1 0 0 0 0 α24λ0µ0 Θ 0 0 0 0 0
0 0 0 0 0 0 0 0 −N 0 0 0 0
0 0 0 0 0 0 0 0 0 −µ2 0 αbλ0µ0 0
0 C4 0 0 0 0 0 0 0 0 −d10 C5 0
0 βi 0 0 0 0 0 0 0 0 0 αe − µB 0
0 C6 0 0 0 0 C7 0 0 0 0 C8 −µ0

Where
Θ = − (α13 + πt + α1 + α16) , C1 = α17 (1− πt)
λ0
µ0









, C6 = −
α17λ0
µ0







To show local stability of the system at DFE, E0, we proceed by applying the Geshgorin
theorem [92] below.







and {λk, k = 1 . . . , n} eigenvalues of A.
Then for all i = 1, . . . , n, λi ∈
n⋃
j=1
Di. Moreover, for an eigenvalue λ of A, |λ− cii| ≤ ri.
Since the Geshgorin theorem is applicable in the complex plane. We now employ it to
our Jacobian matrix. The corollary 3.3.9 states and prove the Geshgorin theorem using
the Jacobian matrix.
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Corollary 3.3.9. Let A = (cij)1≤i,j≤n be a square diagonal matrix with real entries , such that







for all i = 1, . . . , n. Therefore, all the eigenvalues λk, with k = 1, . . . , n have non-positive real
parts.
We use the corollary 3.3.9 to examine the nature of the eigenvalues in the Jacobian ma-










, α12 + µa > 0



























To show that IFE is stable i.e., (R0 < 1). We consider the expressions which are boxed
in (3.3.23), we combine them to obtain,
α17πtλ0µrαe − µiµrαeµ0 + α17πtλ0µrµB − µiµrµBµ0 > αrλrµ0βi.
This implies that
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αe (µiµ0 − α17πtλ0)





















< (2−ω)2 . (3.3.24)
Simplifying the above equation (3.3.24) we obtain
R0 = ω + σ < 1.
















Therefore, we conclude that the MTB infection free equilibrium E0, is locally asymptoti-
cally stable.
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3.3.7.2 Global stability of the infection-free equilibrium
In order to establish the global asymptotic stability, we use the Castillo-Chavez et al,






= G(Z, Y) with G(Z, 0) = 0,
where Y ∈ Rm and Z ∈ Rn denote compartments describing the number of infected
and uninfected cells, respectively. Let E0 be the MTB infection free equilibrium, the two




= F(Z, 0), E0 is globally asymptotically stable.
(I I) Ĝ(Z, Y) = AY− G(Z, Y), Ĝ(Z, Y) ≥ 0 for all (Z, Y) ∈ Ω.
Where A = DzG(E0, 0) is a Jacobian matrix of Ĝ(Z, Y) evaluated at the infection free
equilibrium, which is a metzler matrix (with non-negative-off diagonal components).
Lemma 3.3.10. For the system (3.2.14), global asymptotic stability cannot be guaranteed.
Apply the Castillo-Chavez approach to the system (3.2.14), we get:
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dZ
dt
= F(Z, 0) =














λ0 − α24T0 I121+α4 I4 − µ0T0
− α1T11+α25 I10 −
α13T1
1+α25 I10+α4 I4










αr MrB− αi Mi Iγ + α17πt MiT0 − µi Mi
αi Mi Iγ − µa Ma − µm Ma I2 − µg Ma Iα − α12 Ma1+αkBI10











The Jacobian matrix A is given by:
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− µi 0 αr λrµr
0 − (µa + α12) 0








− µi 0 αr λrµr
0 − (µa + α12) 0














Mi + αr λrµr B
− (µa + α12) Ma
βi Mi + (αe − µB) B

Thus,








Mi − αr MrB + αi Mi Iγ − α17πt MiT0 + αr λrµr B




















+ αi Mi Iγ
It follows that Ĝ1(Z, Y) ≥ 0, since λrµr −Mr ≥ 0 and
λ0
µ0
− T0 ≥ 0, as there is no infection
at the MTB infection free equilibrium.
Furthermore, Ĝ3(Z, Y) = µgNMa Iα ≥ 0, since all parameters are positive and state vari-
ables are non-negative.
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Finally




= −α12Ma − µa Ma −
(





In case of MTB infection, Ma is expected to increase and when there is no infection
Ma = 0, which suggests that
dMa
dt





Ĝ2(Z, Y) ≤ − (α12 + µa) Ma.
This implies that Ĝ2(Z, Y) ≤ 0 as all parameters and state variables are positive. Thus,
since Ĝ2(Z, Y) ≤ 0, i.e., the condition (II) is not fulfilled, the global asymptotic stability
cannot be guaranteed.
In this chapter, we presented the Tuberculosis micro-environment scheme and described
the cell equations for the system (3.2.14). In addition, we performed model analysis,
which includes, positivity of solutions, feasibility of solutions and stability analysis of
the MTB infection free equilibrium. In the next chapter, we present and describe the
methods used to fit the model to experimental data. We use the reproductive number,
R0, to analyse the behaviour of the cell populations.
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In this chapter, we numerically solve our system (3.2.14) and track cell behaviours over
time. Intuitively, we fit our model to experimental data to obtain parameter values that
best describe the cell behaviours during MTB infection. Additionally, we project the
outcome of MTB infection over time. The procedure for model fitting is described in
section 4.1.1 and section 4.1.2, respectively.
4.1 Estimation of parameters
We use non-linear least square (NLS) and Markov Chain Monte Carlo (MCMC) meth-
ods, to estimate parameter values. For the MCMC, The Bayesian inference, with the
likelihood function and prior probability is employed to calculate the posterior proba-
bility. The results from MCMC can be represented graphically.
4.1.1 Non-linear Least Square (NLS) Method
We first let t ∈ R represent time, and y ∈ R13 be a vector of state variables. Let θ ∈ R
be a vector with model parameters and f be a function such that f (t, y, θ). Then our
system (3.2.14) can be written as,
 ddt y(t, θ) = f (t, y, θ),y(0, θ) = y0, (4.1.1)
where y(0, θ) = y0 represent the initial conditions.
The aim of the NLS is to minimise the the sum of squares of errors (SSE) from the actual
data values, y(ti) and the model predicted values ŷ(ti) which depends on the list of
67
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parameters θ. For any n data points (ti, yi), where i = {1, . . . , n}. The objective is to






Suppose that m ≥ n and Rn 7→ Rm. For i = {1, . . . , m}, where m is the estimated
parameters. We want to compute the parameter values (θ) fitting our model. Therefore,
min
θ
M(θ) such that θmin ≤ θi ≤ θmax. (4.1.3)
The above (4.1.3) optimization problem is solved under R, using the desolve package.
Likewise, the optim package is used to fit our model to the actual data in [84].
4.1.2 Markov Chain Monte Carlo (MCMC) Method
Definition 4.1.1. Prior probability - is the probability of observing parameters before an event
or data samples.
Definition 4.1.2. Posterior probability - is the probability of observing parameters with the
availability of data samples.
We now explore the Bayesian-based MCMC method, to inspect the fitted values ob-
tained from the NLS method. We obtain the probability distribution of our model pa-
rameters based on the actual data. The posterior distribution is given by P(θ|y). To
evaluate the posterior distribution, we consider the product of the likelihood P(y|θ)
and prior distribution P(θ), respectively.
Given ŷ(ti) of the system (3.2.14), for the actual data y, with the model parameter θ. We
have that,
y(θ) = ŷ(ti) + ε, (4.1.4)
where ε is the error term, which is the normally distributed Gaussian noise, with mean
µ = 0 and variance δ, denoted by ε ∼ N (0, δ). From the Bayes’ theorem we have,
P(θ|y, δ) = P(y|θ, δ)P(θ, δ)
P(y, δ)
, (4.1.5)
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where P(y, δ) 6= 0 denotes the probability of the actual data. However, since P(y, δ) is a
constant used for normalisation. It follows that,
P(θ|y, δ) ∝ P(y|θ, δ)P(θ, δ). (4.1.6)
We apply the natural logarithm to scale the posterior probability P(θ|y, δ), between 0
and 1, respectively. We obtain,
ln(P(θ|y, δ)) = ln(P(y|θ, δ)) + ln(P(θ, δ)), (4.1.7)
Since the likelihood P(y|θ, δ) is generally represented by L(y, θ, δ). Therefore,
ln(P(θ|y, δ)) = ln(L(y, θ, δ)) + ln(P(θ, δ)), (4.1.8)
where

















We assume the actual data y are independently and identically distributed, denoted by
y iid∼ N (0, δ). And also, the model prior has equal probabilities. After substituting (4.1.9)
in equation (4.1.8), we obtain





























To fit our model to experimental data on the dynamics of MTB infection. We use R
software to compute the Bayesian framework. The experimental data can be accessed
in [84].
4.2 Estimated values and fitted plots
In this section, we perform curve fitting to the observed data, using the NLS and MCMC
methods, respectively. The results of our best model (3.2.14) fit is represented by Fig-
ure 4.2. Of these, we use the parameter values estimated by the NLS method, presented
in Table 4.2. We adopt 18 parameter values from experimental studies.
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(a) NLS method (b) MCMC method
Figure 4.1: The plot showing curve fitting of infected macrophages of model (3.2.14) to
experimental data of MTB infection.
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Parameter Description NLS value MCMC value Units Source
λ0 source of T0 0.99 0.99 cells/ml/day Assumed
λr source of resident macrophages from monocytes 0.99 0.99 cells/ml/day Assumed
α1 production rate of the Iγ by T1 0.18193615 0.601614030 1/day Estimated
α4 inhibition rate of the Iα and Ma proliferation by I4 9.948914e− 01 0.585353464 1/day Estimated
α10 the ability of the B to subvert I10 capacity 2.941191e− 04 0.452665121 pg/ cell day Estimated
α12 production rate of I12 by Ma 9.941308e− 01 0.620366177 pg/ cell day Estimated
α13 production rate of Iα by T1 0.31 0.31 pg/cell day [14]
α15 production rate of I4 by T2 2.18× 10−2 2.18× 10−2 pg/cell day [14]
α16 production rate of I2 by T1 0.12 0.12 pg/cell day [14]
α17 priming rate of T0 by Mi 1.000000e− 07 0.783815492 ml/cell/day [14]
α25 inhibition rate of Iγ response by I10 9.950000e− 01 0.351887193 1/day Estimated
αb priming rate of T2 response by B 1.798849e− 05 0.576115658 ml/cell/day Estimated
αe growth rate of B 0.30 0.30 1/day [14]
αi macrophage activation rate for Mi due to Iγ 1.000000e− 07 0.000000100 ml/cell/day Estimated
αk inhibition rate of I12 production by B using I10 9.765557e− 01 0.619729307 1/day Estimated
αr macrophage infection rate of Mi due to B 4.849652e− 03 0.004395126 ml/cell/day Estimated
βi the capacity of Mi to reduce the bacterial load of B 0.17× 10−2 0.17× 10−2 cell−1 [14]
β10 the capacity of T0 to differentiate 0.0005 0.0005 ml/cell/day Estimated
αtreg the capacity of the I10 to promote T2 response 9.751985e− 01 0.760965613 pg/ cell day Estimated
1− αtreg the capacity of the I10 to inhibit T1 response 0.0248015 0.314356054 pg/ cell day Estimated
µ0 per capita death rate of T0 due to apoptosis 0.3333/500000 0.3333/500000 1/day [14]
µ1 per capita death rate of T1 due to apoptosis 0.3333 0.3333 1/day [14]
µ2 per capita death rate of T2 due to apoptosis 0.3333 0.3333 1/day [14]
µa per capita death rate of Ma due to apoptosis 0.011 0.011 1/day [14]
µg per capita death rate of Ma due to bursting 2.716486e− 03 0.676791106 1/day Estimated
µm per capita death rate of Ma due to I2 1.844496e− 02 0.571452346 1/day Estimated
µi per capita death rate of Mi due to apoptosis 0.011 0.011 1/day [14]
µr per capita death rate of Mr due to apoptosis 0.011 0.011 1/day [14]
µB per capita death rate of B 9.936898e− 01 0.370371992 1/day Estimated
dγ degradation rate of Iγ 2.16× 10−2 2.16× 10−2 1/ day [14]
d2 degradation rate of I2 9.765884e− 01 0.763905182 1/ day Estimated
d4 degradation rate of I4 2.77× 10−2 2.77× 10−2 1/ day [14]
dα degradation rate of Tα 4.143186e− 01 0.396063829 1/day Estimated
d10 degradation rate of I10 3.6968× 10−2 3.6968× 10−2 1/ day [14]
d12 degradation rate of I12 1.188× 10−2 1.188× 10−2 1/ day [14]
πt time delay of T0 priming by Mi 1e− 10 1e− 10 ml/cell/day [14]
N number of released bacteria by Ma , as a result of multiplicity of infection (MOI) 100 100 [14]
4.3 Numerical simulations
In this section 4.3, we perform numerical simulations for the system (3.2.14). The pa-
rameter values used are obtained in Table 4.2, from the NLS method. In addition, we
investigated the switching time from Mi to Ma, and behaviours of cytokines Iγ, I12,
which are responsible for macrophage activation and proliferation. We notice that when
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R0 > 1 switching time from Mi to Ma occurs faster, which is approximately after 8 days.
However, when R0 < 1, the macrophages (Mi to Ma) switch approximately after 9 days.
This dynamics are presented in Figure 4.2a and Figure 4.2b. In addition, from Figure 4.4a
and Figure 4.4b, we observe that I12 increased whenever R0 < 1 and R0 > 1. This sug-
gests that macrophages (Ma) proliferate efficiently. However, for R0 < 1, the observed
increase of Iγ in Figure 4.3a is sufficient to maintain the macrophage activation. The
results in Figure 4.3b shows the increase of Iγ, which is compromised by anti-microbial
activities or other factors. This suggest the need for Iγ to maintain macrophage activa-
tion.
To explore the effect of R0 on T cells response and the switching of the protective im-
munity, from pro-inflammatory to anti-inflammatory immune response. We consider T1
and T2, represented by Figure 4.5a and Figure 4.5b. We can see that R0 > 1 is associ-
ated with deficiency of T1. This might be due to MTB promoting T2 response to impede
anti-microbial perturbations. The cytokines Iα and I4 are more likely candidates for this
switch (T1 to T2).
Iα dynamics are very interesting. The results in Figure 4.9b and Figure 4.6b shows that
in both cases of the reproductive number, i.e., R0 < 1 and R0 > 1. The Iα is highly
expressed and this is associated with MTB dissemination. This supports the findings
that low and high Iα leads to bacterial persistence [23, 66].
(a) The effect of R0 < 1 (b) The effect of R0 > 1
Figure 4.2: The plot showing the effect of stability on the switching time from Mi to Ma.
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(a) The concentration of the Iγ when R0 < 1. (b) The concentration of the Iγ when R0 > 1.
Figure 4.3: The plot showing the effect of stability on the concentration of the IFN-γ.
(a) The concentration of the I12 when R0 < 1. (b) The concentration of the I12 when R0 > 1.
Figure 4.4: The plot showing the effect of stability on the concentration of the I12.
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(a) The effect of R0 < 1 on T1 and T2 response. (b) The effect of R0 > 1 on T1 and T2 response.
Figure 4.5: The plot indicating the effect of stability on the concentrations of the T1 and
T2.
(a) The concentration of the Iα when R0 < 1. (b) The concentration of the Iα when R0 > 1.
Figure 4.6: The plot showing the effect of stability on the concentration of the TNF-α.
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(a) The concentration of the I4 when R0 < 1. (b) The concentration of the I4 when R0 > 1.
Figure 4.7: The plot showing the effect of stability on the concentration of the I4.
In the next section 4.4, we discuss the parameter values altering the dynamics of the
system (3.2.14).
4.4 Sensitivity analysis
To observe the effect of the time delay πt on the reproductive number. We project the
MTB infection by performing simulations for 20 days. As anticipated, when R0 < 1,
the MTB infection is contained by the immune system, as seen in Figure 4.9a, the MTB
load is dropping. In addition, from the results in Figure 4.8a, we can see that the density
of the infected macrophages drops because the MTB load is killed. This correlates with
the results in Figure 4.10a of IL-2. However, when R0 > 1, the results in Figure 4.9b
shows the exponential growth of the MTB infection. We also notice in Figure 4.8b that
the density of infected macrophages is very high, it levels off with a density of 200000
cells/ml/day.
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(a) The Mi cell load when R0 < 1. (b) The Mi cell load when R0 > 1.
Figure 4.8: The plot showing the effect of stability on the Mi cell load.
(a) The plot indicating MTB load (b) The plot indicating MTB load
Figure 4.9: The plot showing the effect of stability on the MTB load.
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(a) The concentration of the I2 when R0 < 1. (b) The I2 concentration when R0 > 1.
Figure 4.10: The plot showing the effect of stability on the concentration of the I2.
(a) The I10 concentration when R0 < 1. (b) The I10 concentration when R0 > 1.
Figure 4.11: The plot showing the effect of stability on the concentration of the I10.
The results from the above Figure 4.10b shows that the infected cells killing by I2 drops
faster when the system (3.2.14) is unstable. This failure of cells killing by I2 leads to the
granuloma formation. As anticipated, the increase in I10 concentration is associated with
unstable, R0 > 1, of the immune system, see Figure 4.11b. Although I10 prevent tissue
damage and inflammation. The ability of I10 to promote MTB growth is supported by
the results in Figure 4.11b. Furthermore, this support the findings that I10 is associated
with high MTB load [58, 76].
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The summary of the results of how the cells are expressed, are presented in the following
Table 4.1.
Table 4.1: Summary of the results.
Variables R0 < 1 R0 > 1 Range when R0 < 1 Range when R0 > 1 Units
Mr decrease decrease (0, 4e + 05) (0, 4e + 05) cells/ml
Mi increase increase (0, 217682) (0, 219530) cells/ml
Ma decrease decrease (0, 533) (0, 0.0295) cells/ml
Iγ increase decrease (0, 20955) (0, 0.0001166893) pg/ml
I2 increase decrease (0, 3111) (0, 2.268018e− 05) pg/ml
I4 decrease increase (0, 0.001137401) (0, 0.03060683) pg/ml
Iα decrease increase (0, 13366) (0, 0.0002106935) pg/ml
I10 decrease increase (0, 10) (0, 486665) pg/ml
I12 decrease increase (0, 0.01148372) (0, 4.491276e− 11) pg/ml
T0 increase decrease (0, 5e + 05) (0, 5e + 05) pg/ml
T1 decrease decrease (0, 498064) (0, 85) pg/ml
T2 increase increase (0, 0.003471331) (0, 0.0004382745) pg/ml
MTB decrease increase (0, 40396) (0, 289049) pg/ml
From the above Table 4.1, the second and third rows represent how the change in sta-
bility affect the cells behaviour. The last three rows represent the biological range of the
cells with respect to the stability. The remaining last row shows the units of the state
variables in the system (3.2.14). We observe that the increase in the anti-inflammatory
response is associated with MTB persistence.
In this chapter, we performed curve fitting to model (3.2.14), using the NLS and MCMC
methods, respectively. In addition, we further explore the dynamics of the MTB in-
fection by performing numerical simulations and sensitivity analysis. In section 4.4,
we performed numerical simulations to track the behaviour of the system (3.2.14). We
analysed the system (3.2.14) based on the reproductive number, R0. We noticed that
when R0 < 1, the system (3.2.14) is able to contain the MTB infection. However, when
R0 > 1, the MTB persists resulting in over-expression of the anti-inflammatory immune
response. In the next chapter, we use findings from our analysis to make concluding
remarks.
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Conclusion
In this study, we developed a mathematical scheme aimed at elucidating the cellular
dynamics of the human immune response to MTB infection. This scheme incorporated
and described the key roles of the different cells compartments of macrophages, T cells
and cytokines, respectively. For macrophages, we considered intracellular MTB within
macrophages and tracked the process of phagocytosis. In addition, we included the time
delay to account for the microbial perturbations by MTB, in defence to anti-microbial ac-
tivities by macrophages. The extracellular bacteria is captured by including the dummy
parameter N, for released bacterial load after failure of phagocytosis.
Furthermore, we inspected and analysed the dynamics of T cells response, both pro-
inflammatory and anti-inflammatory. For pro-inflammatory, we examined the roles of
four potent cytokines namely, IFN-γ, TNF-α, IL-2 and IL-12. The biology and roles of
this cytokines are well addressed in Chapter 3. In addition, we looked at two regulatory
cytokines IL-4 and IL-10, respectively. In fact, our focal point was to analyse how regu-
latory cytokines affect the stability of the protective immunity.
We employed the non-least square (NLS) and Markov Chain Monte Carlo (MCMC)
methods to fit our system (3.2.14) to the observed data in [84], on mice infected with
MTB. To analyse our results, we use the reproductive number thresholds R0 < 1 and
R0 > 1 as our factor. The results from this fit showed progression of the MTB infection
when the time delay is increased. In fact, from the numerical simulations and sensitivity
analysis, when the time delay is increased the system (3.2.14) is unstable (i.e, R0 > 1).
This suggest there are more infected macrophages, leading to high MTB load. To anal-
yse this impediment, we looked at the switching time (Mi to Ma) and infected cell killing
79
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by IL-2. In Figure 4.2b, we see that the switching time decrease when time delay is in-
creased. This point out insight on the inefficiency of cell termination by IL-2. Indeed,
the Figure 4.10b shows that the time delay negatively affects cytotoxicity of IL-2.
The cytokines IFN-γ, TNF-α, IL-2 can be considered to be amplified for TB vaccine de-
sign. Although the levels of IFN-γ collapsed when R0 > 1. This is due to the deficiency
of the type 1 helper T cells. Thus, IFN-γ remains the potent cytokine for protective im-
munity against MTB infection. The IL-2 can be aided to kill and clear the bacterial load
within infected cells. Since its depletion is associated with high bacterial load. In addi-
tion, we have shown that high levels of TNF-α and low levels of IL-2 are associated with
MTB growth.
For future research, the inclusion of the chemokines and receptors can enhance the vi-
ability of our study. In addition, performing sensitivity analysis on the cytokines and
chemokines can provide interesting insight on the dynamics of MTB infection.
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